International Frameworks Dealing with Human Risk Assessment of Combined Exposure to Multiple Chemicals by European Food Safety Authority
   EFSA Journal 2013;11(7):3313 
 
Suggested citation: European Food Safety Authority, 2013. International Framework Dealing with Human Risk Assessment 
of  Combined  Exposure  to  Multiple  Chemicals.  EFSA  Journal  2013;11(7):3313.  [69  pp.]  doi:10.2903/j.efsa.2013.3313. 
Available online: www.efsa.europa.eu/efsajournal  
© European Food Safety Authority, 2013 
SCIENTIFIC REPORT OF EFSA 
International Frameworks Dealing with  
 Human Risk Assessment of Combined Exposure to Multiple Chemicals
1,  
European Food Safety Authority
2,
3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The  development  of  harmonised  terminology  and  frameworks  for  the  human  risk  assessment  of  combined 
exposure to multiple chemicals (“chemical mixtures”) is an important area for EFSA and a number of activities 
have already been undertaken, i.e. in the fields of pesticides and contaminants. The first step prior to a risk 
assessment of combined exposure to multiple chemicals is problem formulation defining the relevant exposure, 
hazard and population to be considered. In practice, risk assessment of multiple chemicals is conducted using a 
tiered  approach  for  exposure  assessment,  hazard  assessment  and  risk  characterisation.  Higher  tiers  require 
increasing knowledge about the group of chemicals under assessment and the tiers can range from tier 0 (default 
values, data poor situation) to tier 3 (full probabilistic models). This scientific report reviews the terminology, 
methodologies and frameworks developed by national and international agencies for the human risk assessment 
of combined exposure to multiple chemicals and provides recommendations for future activities at EFSA in this 
area.  
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SUMMARY 
Human risk assessment of combined exposure to multiple chemicals (chemical mixtures) poses several 
challenges  to  scientists,  risk  assessors  and  risk  managers,  particularly  the  complexity  of  the 
terminology and problem formulation, the diversity of chemical entities, and the toxicological profiles 
and  exposure  patterns  in  test  species  and  humans.  This  scientific  report  aims  to  describe  the 
terminology and methodologies, review frameworks developed by national and international agencies 
and discuss future activities at EFSA in this area.  
The use of harmonised terminology is an important step when dealing with multiple chemicals. This 
scientific report refers to “ risk assessment of combined exposure to multiple chemicals” in order to 
support such harmonisation in terminology as proposed by the International Programme on Chemical 
Safety  of  the  World  Health  Organisation  (WHO).  However,  the  use  of  this  terminology  is  not 
restrictive; for example, the term “cumulative risk assessment” is used in the pesticide field for the 
settings of Maximum Residue Levels (MRLs) under Regulation (EC) No 396/2005. 
Problem formulation is the first step prior to performing a risk assessment of combined exposure to 
multiple chemicals and throughout the world different approaches exist. The US-EPA approach aims 
to identify the classes /groups of chemicals to be assessed, the relevance and significance of exposure 
to  such  chemicals,  the  population(s)  exposed  and  the  assumptions  formulated  based  on  the 
knowledge/uncertainty related to the chemicals under assessment. Relevance of co-exposure has been 
acknowledged  by  the  US-EPA,  ATSDR,  the  WHO  and  the  three  Non  Food  Committees  of  the 
European  Commission  as  the  critical  issue  when  prioritising  multiple  chemicals  for  possible  risk 
assessment. In Europe, in the context of EFSA‟s remit, problem formulation is often dealt with in the 
terms of reference. The terms of reference define the hazard to be assessed within a particular legal 
framework  and  are  often  provided  by  risk  managers  either  from  the  European  Commission  or  a 
Member State. An example of high relevance is the risk assessment of combined exposure to multiple 
pesticides in food under Regulation (EC) 396/2005 for which Cumulative Assessment Groups have to 
be defined based on hazard data to set MRLs. 
Risk  assessment  for  multiple  chemicals  is  then  conducted  using  a  tiered  approach  for  exposure 
assessment,  hazard  assessment  and  risk  characterisation.  The  tiers  range  from  qualitative/semi-
quantitative  tier  0  to  fully  probabilistic  tier  3  (probabilistic  models  for  exposure  assessment  and 
physiologically-based  models  for  hazard  assessment).  The  choice  of  the  tier  depends  on  data 
availability, the purpose of the risk assessment and the resources available. 
For hazard assessment, either a whole mixture approach or component-based approaches are applied. 
The whole mixture approach is used when toxicological data are available either for the mixture itself 
or for a sufficiently similar mixture which can then be used as a surrogate for the mixture under 
evaluation. Component-based approaches are preferred methods when dose response data for specific 
toxicity endpoints of individual components are known so that substances can be placed in cumulative 
assessment groups/assessment groups (CAGs/AGs). Ideally mode/mechanism of action (MOA/MEA) 
information is used to select CAGs/AGS using assumptions of additivity (dose addition, response 
addition)  or  interaction  (synergism,  antagonism)  amongst  the  multiple  chemicals.  However,  such 
MOA/MEA data are rarely available and the scientific criteria for setting CAGs/AGS are often based 
on target organ toxicity. 
Additivity is the most common assumption and supposes that combined toxicity of multiple chemicals 
is additive through either dose addition with a similar MOA or response addition with a dissimilar 
MOA. Methods using the dose addition assumption include theHazard Index approach with variants 
such as the target-organ toxicity dose, the reference point index/point of departure index, the relative 
potency  factor  and  the  toxicity  equivalency  factor  approaches.  For  multiple  chemicals  with  a 
dissimilar MOA, the probability of observing a toxic response for each chemical component in the Combined exposure to multiple chemicals 
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mixture is first estimated and components are then summed to estimate total risk from combined 
exposure to the multiple chemicals. 
Using the assumption of interactions (toxicokinetic and toxicodynamic), combined toxicity for the 
multiple chemicals is categorised as either less than additive (antagonism, inhibition, masking) or 
greater than additive (synergism, potentiation). Methods for deriving risk estimates for interactions 
include interaction-based Hazard Index and Hazard Index modified for binary interactions. 
For  high  tier  risk  assessment  (tier  3),  full  probabilistic  models  can  be  developed  for  exposure 
assessment  and  physiologically-based  toxicokinetic  (PB-TK)  models  and  physiologically-based 
toxicokinetic-toxicodynamic (PB-TK-TD) models for hazard assessment. A typical example of the use 
of a PB-TK includes the derivation of interaction-based Hazard Index using tissue doses accounting 
for multiple toxicokinetic interactions between the multiple chemicals. 
Uncertainty analysis in the context of a risk assessment of combined exposure to multiple chemicals is 
used for the identification of the sources and magnitude of uncertainty in a tiered manner (qualitative, 
semi-quantitative or probabilistic) associated with exposure assessment, hazard assessment and risk 
characterisation. In addition, it provides the opportunity to identify data gaps, strengths and limitations 
of  the  assessment  (whether  further  refinements  of  the  assessment  are  needed)  and  to  make 
recommendations on future research. 
Most  national  and  international  frameworks  described  in  this  report  apply  step  wise  decision 
trees/tiered approaches for the risk assessment of combined exposure to multiple chemicals based on 
the original framework developed at the US-EPA. The main differences between the frameworks are 
in the lay-out rather than in the methodologies. These include the US-EPA, the Agency for Toxic 
Substances and Disease Registry (ATSDR), the Norwegian Committee for Food Safety (VKM), the 
UK‟s Interdepartmental Group on Health Risks from Chemicals, the three Non-Food Committees of 
the  European  Commission  (Scientific  Committee  on  Health  and  Environmental  Risks  –  SCHER, 
Scientific  Committee  on  Emerging  and  Newly  Identified  Health  Risks  –  SCENIHR,  Scientific 
Committee on Consumer Safety – SCCS) and EFSA. Key differences between frameworks include the 
separation of two different frameworks for cancer and non-cancer effects (ASTDR) versus the use of 
single tiered approach (three Non-Food Committees, WHO) and the use of dose addition as the basis 
of the setting of assessment groups unless evidence demonstrates otherwise and requires refinement of 
the assessment (WHO, three Non-Food Committees, EFSA). 
EFSA‟s  Panel  on  Plant  Protection  Products  and  their  Residues  (PPR  Panel)  evaluated  different 
methods/approaches  for  their  suitability  in  the  risk  assessment  of  combined  dietary  exposure  to 
pesticides in food for MRL setting and applied them in a practical exercise to a group of triazole 
fungicides.    Since  refined  cumulative  exposure  assessments  can  only  be  done  with  probabilistic 
methods, guidance proposing a methodology for performing probabilistic exposure assessments for 
cumulative risk assessment was also developed by the PPR Panel. In 2013, the PPR Panel proposed a 
general methodology to establish cumulative assessment groups (CAGs) for pesticides. The approach 
essentially proposes to group pesticides in CAGs when they cause the same toxicological effect on the 
same target organ or organ system even if the MOA or underlying biochemical events causing the 
effects (MEA) are not comprehensively elucidated. However, if mechanistic information is available 
(i.e. MOA/MEA) it can be used for the refinement of CAGs. On the basis of the proposed general 
methodology and an evaluation of data presented in Draft Assessment Reports (DARs) supporting the 
approval of pesticides in the EU, the PPR opinion presented and derived CAGs for pesticides affecting 
adversely  the  nervous  system  and  the  thyroid  system  respectively.  In  order  to  complement  and 
safeguard  the  general  methodology  developed  for  setting  CAGs,  the  PPR  Panel  will  develop  a 
scientific opinion exploring the relevance of dissimilar MOA (i.e. response addition or independent 
action) for cumulative risk assessment of pesticides. This opinion is due for publication at the end of 
2013.  Combined exposure to multiple chemicals 
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In another context, EFSA‟s Panel on Contaminants in the Food Chain (CONTAM Panel) has applied a 
dose addition for the risk assessment of combined exposure to multiple contaminants using both whole 
mixture and component-based approaches. The whole mixture approach has been applied to mineral 
oil  saturated  hydrocarbons  and  hexabromocyclododecanes.These  approaches  have  included  whole 
mixture approaches (e.g mineral oil saturated hydrocarbons, hexabromocyclododecanes). Component-
based approaches have included a TEF approach for non-ortho polybrominated biphenyls (PBBs) and 
several groups of marine biotoxins and modelling of BMDLs for an index chemical to derive group 
Acute Reference Dose/Tolerable Daily Intake (e.g.ergot alkaloids) or margin of exposures (MOEs) 
(e.g. polyaromatic hydrocarbons, pyrrolizidine alkaloids).   
Future activities at EFSA in this field are proposed based on a number of sources: the conclusions and 
follow up action from the European Commission in their reply to the European Council, a review of 
the literature/consultation of experts from the Scientific Committee, Scientific Panels and Units of 
EFSA and the recent PPR Panel opinion on CAGs of pesticides.  
Harmonised  terminology  and  methodologies  for  human  risk  assessment  of  combined  exposure  to 
multiple chemicals in the food safety area as well as in animal and ecological risk assessment are key 
objectives that need further work at EFSA. Such activities are expected to contribute to developing a 
consistent approach to the assessment of priority mixtures across the different EU  regulations and 
directives. Another future activity in the longer term includes the development of methodologies for 
risk  assessment  of  exposure  to  multiple  chemicals  combined  with  other  stressors  (e.g.  biological 
hazards, physical agents).  
For  problem  formulation,  this  report  recommends  identification  of  priority  chemicals  using  both 
exposure- and hazard-based criteria which can then be integrated so that guidance can be provided 
taking into account differences in legal frameworks (i.e. regulated substances versus contaminants). 
For exposure assessment, recommendations include collection of occurrence data for multiple priority 
chemicals  in  individual  food  samples,  the  development  of  case  studies/training  sets  to  compare 
deterministic versus probabilistic methods, and methodologies for aggregate exposure assessment for 
priority chemicals.  
Future activities for hazard assessment include further exploration of the scientific basis for both the 
whole  mixture  approach  and  the  setting  of  assessment  groups  for  component-based  approaches 
particularly using mode of action information. A key recommendation is to gain better information 
regarding MOA/MEA of multiple substances since such data are lacking for most regulated and active 
substances (pesticides) and contaminants. Such data can be generated from toxicokinetic and toxicity 
studies  as  well  as  using  predictive  and  alternative  methodologies  (including  QSAR  and  OMICs). 
Another future activity to improve the basis for setting CAGs/AGs is the collection of toxicokinetic 
and toxicodynamic data for multiple chemicals of priority in humans and major test species. This 
activity  has  recently  started  with  a  procurement  dealing  with  “systematic  review  on  metabolic 
interactions  and  synergistic  effects  of  chemical  mixtures  for  human  risk  assessment”  for  over 
100 chemicals  of  relevance  to  EFSA.  Finally,  this  report  also  recommends  the  development  of  a 
guidance document for uncertainty analysis regarding hazard assessment and risk characterisation for 
multiple chemicals.  Combined exposure to multiple chemicals 
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BACKGROUND AS PROVIDED BY EFSA 
The toxicology of chemical mixtures is a very complex and relevant topic in the area of food and feed 
safety. For EFSA, the development of a framework for the risk assessment of chemical mixtures is an 
important topic and since the creation of EFSA a number of activities have been developed to fulfil 
this  goal.  EFSA‟s  Panels  are  frequently  confronted  with  questions  to  address  the  health  risks  of 
combined exposures to multiple (cocktails of) chemicals via the diet, in some cases also via multiple 
sources (e.g. via inhalation, consumer products). In order to ensure the application of a harmonised 
approach for the scientific evaluation of chemical mixtures by the various Panels and Units, there is a 
need  to  review  the  state-of-the-art  frameworks  already  in  practice  at  the  international  level.  The 
increased attention to this issue in the media and scientific literature shows the merit of developing 
such a harmonised approach across EFSA‟s chemical risk assessment activities. 
Previous and ongoing EFSA activities 
In 2006, an EFSA Colloquium on “Cumulative Risk Assessment of Pesticides to Human Health: The 
Way Forward” was hosted in Parma. The purpose of the colloquium was to open a scientific debate on 
the scientific approaches, methods available and data needed to perform human risk assessment of 
pesticide mixtures under specific circumstances: (1) cumulative risk assessment for pesticides with a 
common  mode  of  action  (dose-addition);  (2)  scientific  basis  for  combining  pesticides  in  hazard 
assessment, with dissimilar mode of action (response-addition, possible synergistic or antagonistic 
effects) (3) choice of data and methodology for combined exposure assessment; and (4) possible joint 
efforts between EU Member States, EFSA and non-EU Member States and international organisations 
such as the WHO to further develop harmonised approaches in the cumulative risk assessments of 
pesticides (EFSA, 2007). In 2008, the Panel on Plant Protection Products and their Residues (PPR 
Panel)  published  an  opinion  on  existing  approaches  and  new  methodologies  to  assess  possible 
cumulative and synergistic risks from pesticides to human health with a view to set MRLs in the frame 
of  Regulation  (EC)  No  396/2005  (EFSA,  2008a).  In  2009,  the  PPR  Panel  applied  the  proposed 
methodology to a group of triazole compounds with a common mode of action (EFSA, 2009a).  
In addition, the Scientific Committee and Advisory Forum unit (SCAF) launched an Article 36 project 
in 2009 to review the scientific literature regarding the toxicology of chemical mixtures of relevance 
to food and feed safety. The outcomes of this project have been incorporated into a database with 
chemical-specific  toxicokinetic  and  toxicodynamic  parameters  for  a  range  of  chemical  mixtures 
(EFSA, 2010). 
In 2009, the PPR unit has awarded a grant dealing with the identification of cumulative assessment 
groups  of  pesticides  using  existing  pesticide  databases,  the  open  literature  and  Draft  Assessment 
Reports to identify toxicological effects/endpoints as the basis of a cumulative risk assessment and 
consequently propose common assessment groups of active substances having such effects. Overall, 
the aim of this project, finalised in April 2011, is to set the basis for cumulative risk assessments on a 
routine basis in MRL setting. Finally, the PRAS (formerly PPR) unit launched two external contracts 
to provide: (1) a state of the art review on combined actions of chemicals in food acting through 
dissimilar modes of action to define criteria for cumulative assessment groups of pesticides with a 
dissimilar  mode  of  action;  and  (2)  to  collect  and  assess  data  relevant  to  non-dietary  cumulative 
exposure to pesticides and proposals to develop new approaches for non-dietary cumulative exposure 
assessment in operators, works, bystanders and residents.  
National and International activities 
In Europe, a number of reviews and guidance documents have been published by national agencies 
(COT, 2002; Norwegian Scientific Committee for food safety, 2008) and recently by the European 
Commission‟s DG Environment “State of the Art Report on Mixture Toxicity” (Kortenkamp et al., 
2009).  Combined exposure to multiple chemicals 
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From an international perspective, a number of guidance documents and frameworks for the risk 
assessment of chemical mixtures have been developed:  
-  the  US-EPA  published  general  guidelines  and  applied  them  specifically  to  pesticides  including 
organophosphates (US-EPA, 1986, 2000, 2002, 2003, 2007); 
- the ATSDR including interaction profiles of a number of substances (Arsenic, Cadmium, Chromium, 
Lead; atrazine, Deethylatrazine, Diazinon, Nitrate, and Simazine; chlorpyrifos, Lead, Mercury, and 
Methylmercury) (ATSDR, 2004a, b, 2006a, b);  
- the International Program on chemical Safety (IPCS) of the WHO developed a general framework 
fro the risk assessment of chemical mixtures (Meek et al., 2011). The framework which applied to a 
number of classes of substances (solvents, pesticides, food additives, pharmaceuticals…) was recently 
discussed at a WHO/OECD/ILSI-HESI workshop held at the OECD, Paris (15-16 February, 2011) 
(OECD, 2011). 
Needs for EFSA’s future activities 
The recent report describing the science strategy of EFSA for 2012-2015 identified chemical mixtures 
as one of the priority tasks for the coming years. Moreover, EFSA‟s Scientific Committee, Advisory 
Forum, the press and the media have shown interests and concerns about possible so called “cocktail 
effects”. An internal task force aiming to further harmonise these methods, through a scientific review 
of available international frameworks, is therefore required to provide a starting point for further 
development of a harmonised framework to be applied by EFSA‟s Panels and Units. The internal task 
force will also consult international external experts from other agencies/expert groups, such as WHO 
and the US-EPA who have been involved in the development of such frameworks to make sure that 
the review of the framework is comprehensive.  Future activities can be anticipated in this area to 
move towards more mechanism-based and quantitative risk assessment of chemical mixtures. This is 
particularly relevant to pharmaceuticals and contaminants for which in vitro data and quantitative 
human  data  are  available,  at  the  metabolic,  pharmacokinetic/toxicokinetic, 
pharmacodynamic/toxicodynamic and epidemiological level. Finally, depending on the circumstances, 
possible applications of the use of in vitro human data and/or epidemiological data can be explored. 
Such use would contribute to the 3Rs (reduce, replace, refine) moving towards the reduction of animal 
use in toxicological research and has already been applied by a number of EFSA Scientific Panels for 
specific chemicals. 
TERMS OF REFERENCE AS PROVIDED BY EFSA  
The EMRISK unit is requested to establish an internal task force with staff members from the Science 
Directorates. 
The specific aims of the task force are: 
- To review the frameworks developed by national and international risk assessment bodies and by 
EFSA for the human health risk assessment of chemical mixtures. 
-To prepare a scientific report to summarise available methodologies and frameworks for the risk 
assessment of chemical mixtures in food and feed safety with recommendations for future work in 
EFSA. 
- To present the outcomes of this work to the Scientific Committee for further consideration. 
-To keep the communication directorate informed on the progress of the scientific review.  Combined exposure to multiple chemicals 
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CONTEXT OF THE SCIENTIFIC OUTPUT  
This scientific report aims to support EFSA‟s science strategy for 2012-2016 in the specific context of 
objective 3 “ Develop and harmonise methodologies and approaches to assess risks associated with the 
food  chain”  under  “New  risk  assessment  methodologies”.  It  aims  to  support  EFSA‟s  Scientific 
Committee and Panels to further develop a harmonised and consistent approach for the human health 
risk  assessment  of  combined  exposure  to  multiple  chemicals  (chemical  mixtures)  in  food.  “The 
potential simultaneous exposure to  a  multitude  of  hazards  (chemicals,  micro-organisms  and  other 
effectors) possibly through different routes also highlights the necessity to move beyond the single 
hazard approach and consider e.g. chemical mixtures (combined exposure to multiple chemicals). The 
EFSA Scientific Panel on Plant Protection Products and their Residues (PPR) has already elaborated a 
framework for the human risk assessment of  multiple pesticide residues and applied it to triazole 
fungicides (EFSA, 2008a, 2007, 2009a). Other Scientific Panels such as the Panel on Contaminants in 
the Food Chain (CONTAM Panel) have also dealt with the risk assessment of multiple contaminant 
residues, and developed specific approaches (EFSA, 2011, 2012a).  Combined exposure to multiple chemicals 
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EVALUATION 
1.  Introduction 
Human risk assessment of combined exposure to multiple chemicals: “chemical mixtures” is a major 
challenge to scientists, risk assessors and risk managers particularly from the methodological point of 
view in relation to the complexity of the terminology and problem formulations, the diversity of 
chemical entities, and the toxicological profiles and exposure patterns in test species and humans. 
In  the  European  Union,  multiple  chemicals/chemical  mixtures  are  assessed  and  regulated 
predominantly for intentional mixtures and in some cases complex mixtures discharged/emitted to the 
environment from a single source (factory, facility, etc.) (EC, 2012a). Examples of legislation for 
intentional  mixtures  include  Regulation  (EC)  No  1272/2008  for  the  classification,  labelling  and 
packaging of mixtures (EC, 2008), Regulation (EC) No 1107/2009 concerning the placing of plant 
protection  products  on  the  market  (EC,  2009a),  Regulation  (EC)  No  1223/2009  governing  the 
composition  of  cosmetics  (EC,  2009b),  regulation  2001/83  governing  the  approval  of  medicinal 
products  for  human  use  and  Regulation  (EC)  No  2001/82  governing  the  approval  of  veterinary 
medicinal products (EC, 2001a,b). For pesticides, article 4 of Regulation (EC) No 1107/2009 of the 
European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection 
products on the market and article 14 of Regulation (EC) No 396/2005 on Maximum Residue Levels 
(MRLs) for pesticides in food both establish approval criteria for active substances and criteria for 
MRL  setting  respectively  (EC,  2005)  and the recent  Biocide  Regulation  (EC)  No  528/2012  (EC, 
2012b). Both regulations particularly emphasise the importance “to carry out further work to develop a 
methodology  to  take  into  account  cumulative  and  synergistic  effects  of  pesticides”.  For  multiple 
substances arising from multiple sources, limited examples of EU legislation are available, the major 
one being the REACH Regulation (EC) No 1907/2006. In this context, guidance has been developed 
to deal with the assessment of multiple sources of exposure to a single substance and in specific cases 
to the assessment of several closely related and similarly acting substances (e.g. different salts of the 
same metal or a number of closely related derivatives of organic substances) (EC, 2006). In term of 
occupational  risk  assessment,  Council  Directive  98/24/EC  requires  employers  to  carry  out  risk 
assessments of hazardous chemicals in combination (EC, 1998).  
Over the last decade, public authorities around the globe such as the US-Environmental Protection 
Agency  (US-EPA),  the  Agency  for  Toxic  Substances  and  Disease  Registry  (ATSDR),  the 
International Programme on Chemical Safety (IPCS) of the World Health Organisation (WHO), the 
three non food Committees of the European Commission, and EFSA have made considerable progress 
in developing pragmatic frameworks “fit for purpose” and tiered approaches to deal with combined 
exposure to multiple chemicals for risk assessment purposes (US-EPA, 1986; 2000, 2007; ATSDR, 
2004a; EFSA, 2008a; EFSA, 2009a; WHO, 2009; Meek et al., 2011; SCCS, SCHER, SCENIHR, 
2012).  Generally  speaking,  these  frameworks  for  human  risk  assessment  deal  with  problem 
formulation to define the mixture to be assessed and the relevance of exposure to human health prior 
to the risk assessment which then apply methodologies for hazard identification and characterisation, 
exposure assessment and risk characterisation depending on the chemical mixture and availability of 
toxicological and exposure data. 
This present scientific report deals with methodologies for the human risk assessment of combined 
exposure to multiple chemicals, so-called “chemical mixtures”. The general terminology and a general 
overview of the available methodologies together with summaries of the frameworks developed by 
national and international agencies throughout the world to provide a road map for future activities at 
EFSA in the food safety area. It is noted that environmental risk assessment is beyond the scope of this 
scientific report. Combined exposure to multiple chemicals 
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2.  General Terminology 
The use of harmonised terminology is an important step for a common understanding of the key terms 
and  concepts  that  are  used  when  dealing  with  combined  exposure  to  multiple  chemicals  for  risk 
assessment  purposes.  However,  to  date  no  internationally  or  harmonised  terminology  for  the 
assessment of mixtures and combinations of chemicals has been adopted as pointed out by the three 
Non-Food Scientific Committees of the European Commission Consumer Safety (SCCS), Health and 
Environmental  Risks  (SCHER)  and  Emerging  and  Newly  Identified  Health  Risks  in  their  recent 
opinion on “toxicity and assessment of chemical mixtures” (SCCS, SCHER, SCENIHR, 2012). In 
order to provide an overview of the terminology, a number of generic concepts and definitions that are 
used throughout this report are presented first presented below. These definitions and concepts drawn 
from  the  US-EPA,  the  ATSDR  (ATSDR,  2001,  2004a),  the  Kortenkamp  et  al.  (2009)  report 
commissioned by the Directorate-General Environment of the European Commission), the three non 
food Committees of the European Commission (SCCS, SCHER, SCENIHR, 2012), the WHO/IPCS 
(WHO,  2009,  Meek  et  al.,  2011,  OECD,  2011)  and  the  work  of  the  Scientific  Panel  on  Plant 
Protection Products and their Residues (PPR) of EFSA (EFSA, 2008a, 2009a, 2012a, b, 2013).  
2.1.  Cumulative risk assessment and combined exposure to multiple chemicals 
The  US-EPA  has  defined  cumulative  risk  assessment  as  “an  analysis,  characterisation,  and 
possible quantification of the combined risks to health or the environment from multiple agents or 
stressors”, with further definitions (US-EPA, 2002, 2003, 2007):  
  Cumulative  exposure:  “combined  exposure  to  multiple  chemicals  including  all  routes, 
pathways, and sources of exposure to multiple chemicals”  
  Cumulative  risk:  “the  combined  risks  from  aggregate  exposures  to  multiple  agents  or 
stressors” which may include chemicals, as well as biological or physical agents. 
 In March, 2007, the WHO/IPCS on Aggregate/Cumulative Risk Assessment (Combined Exposures to 
Multiple  Chemicals)  recommended  to  replace  the  term  “cumulative”  which  can  be  potentially 
misleading with “combined exposure to multiple chemicals” and these working definitions have been 
subsequently adopted by the IPCS/ WHO framework developed for “combined exposure to multiple 
chemicals” (WHO, 2009; Meek et al, 2011; OECD, 2011). The IPCS also proposed to distinguish 
„„cumulative exposure” corresponding to two different exposure scenarios: “combined exposure to 
multiple chemicals by multiple routes” and “combined exposure to multiple chemicals by a single 
route”.  
In contrast, „„aggregate exposure” represents “exposure to a single substance from multiple sources 
and by multiple pathways and routes”, also described as „„single chemical, all routes” (WHO, 2009). 
In  order  to  support  harmonisation  of  terminology,  this  scientific  report  also  refers  to  “combined 
exposure to multiple chemicals” in line with the terminology adopted by the WHO/IPCS. However, in 
the  context  of  the  European  Pesticide  Regulation  (EC)  No  396/2005  the  term  “cumulative  risk 
assessment” is used for setting Maximum Residue Levels (MRLs) for multiple pesticide residues in 
food and consequently this term is used by the PPR Panel of EFSA (EC, 2005). In the context of this 
scientific  report  the  term  “cumulative  risk  assessment”  is  considered  equivalent  to  “combined 
exposure to multiple pesticides by the oral route”, since the oral route is of most relevance for food 
(EFSA, 2008a, 2009a).  
2.2.  Mixtures 
 As described above, the term “combined exposure to multiple chemicals” is preferred to the term 
“mixtures” but since a number of national and international agencies use the term “mixture in its 
historical context.  Combined exposure to multiple chemicals 
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  A “mixture” has been defined as “any combination of two or more chemicals, regardless of 
source and spatial or temporal proximity, that may jointly contribute to actual or potential effects 
in a receptor population.” (US- EPA 1986, 1999; ATSDR, 2004a). From a global perspective, 
chemical mixtures can be “intentional mixtures” such as regulated and manufactured products 
(i.e. pesticide formulations, gasoline, or laundry detergents) while others may be generated as by-
products  of  processes  (i.e.  smelting,  drinking  water  disinfection,  fuel  combustion,  cigarette 
smoking). Additionally, chemical mixtures of concern at hazardous waste sites are qualified as 
“coincidental mixtures” since they are composed of unrelated chemicals from different sources, 
deposited separately at a particular site, but having the potential to reach the same “receptor 
population” by their presence in or migration into the same medium (commonly groundwater), or 
through a combination of media and pathways (ATSDR, 2004a).  
ATSDR has described three broad types of mixtures in relation to their composition: simple, complex 
and similar mixtures.  
  “Simple mixtures” are defined as a combination of a relatively small number of chemicals (no 
more than 10) that have been identified and quantified (e.g., the components of concern for a 
receptor population near a hazardous waste site may constitute a simple mixture).  
  “Complex mixtures” are defined as a combination of so many chemicals that the composition 
of the mixture is not fully characterised, either qualitatively or quantitatively, and  may be 
variable (e.g., cigarette smoke, diesel exhaust, gasoline). “Similar mixtures” are defined as 
having the same chemicals but in slightly different proportions or having most but not all 
chemicals in common and in highly similar proportions. Similar mixtures were expected to 
have similar fate, transport, and health effects (e.g., the jet fuel JP-5 from different sources) 
(ATSDR, 2004a). 
  Recently, the IPCS of the WHO has noted that some authors refer to simple and complex 
mixtures  based on  their  toxicological/biological  activity  (WHO,  2009;  Meek  et  al.,  2011) 
i.e. multiple  chemicals that  act  by  a  similar  or  dissimilar  mode  of  action are qualified as 
simple and complex mixtures respectively. 
Information on toxicity of complex or simple mixtures are then integrated and scientists will apply 
“whole  mixture  approaches”  when  data  are  available  on  a  whole  mixture  or  “component  based 
approaches” when data are available on specific compounds. Such information may be available for 
different levels of biological organisations such as target organ level, cellular and biochemical level 
(mode of action), or biochemical/molecular level (mechanism of action). 
2.3.  Mode of action and Mechanism of Action 
   “Mode of Action (MOA)” refers to the “biologically plausible sequence of key events leading 
to an observed effect supported by robust experimental observations and mechanistic data. It 
refers  to  the  major  steps  leading  to  an  adverse  health  effect  following  interaction  of  the 
compound with biological targets; it does not imply full understanding of mechanism of action 
at the molecular level (Boobis et al., 2006; EFSA, 2008a, 2013). 
  “Mechanism of Action (MEA)” refers to “a detailed explanation of the individual biochemical 
and physiological events leading to a toxic effect” (Boobis et al., 2006; EFSA, 2008a, 2013).  
In  the  context  of  multiple  chemicals,  Teuschler  (2007)  considered  MOA  and  MEA  as  part  of  a 
continuum of mechanistic information that includes knowledge ranging from general toxicology at the 
target organ level to key cellular and biochemical events (MOA) at the molecular level (MEA) to 
characterise  Adverse  Outcome  Pathways  (AOP)  such  as  the  perturbation  of  molecular  signalling 
involved in cellular functions and homeostasis.  Combined exposure to multiple chemicals 
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It is well recognised that MOA and MEA data are rarely available for chemicals and very often only 
basic toxicological information such as target organ/pathological information is known either for a 
whole mixture or specific chemicals as re-emphasised recently by the PPR Panel of EFSA (EFSA, 
2013). Methods for hazard assessment and risk characterisation of combined exposure to multiple 
chemicals  for  whole  mixture  approaches  and  component-based  approaches  are  discussed  in  the 
following Chapter (3.4 hazard assessment and risk characterisation).  
2.4.  Combined toxicity of multiple chemicals: Dose Addition, Dissimilar Mode of Action-
Response Addition and Interactions 
Combined toxicity is defined as the “response of a biological system to several chemicals, either after 
simultaneous  or  sequential  exposure  and  can  take  three  possible  forms:  dose-addition,  response-
addition or interaction” (Loewe and Muischnek, 1926; EFSA, 2013).  
2.4.1.  Dose Addition  
Dose-addition (also known as simple similar action, similar joint action or relative dose-addition, 
concentration addition) is the most common approach for the assessment of combined exposure to 
multiple chemicals and assumes that all components of a “mixture” behave as if they were a simple 
dilution of each other (Bliss, 1939; EFSA, 2013) and have a similar MOA. Historically, the dose 
addition assumption is based on the pharmacological concepts of ligand binding site theory, affinity, 
potency and receptor occupancy. Hence, receptor occupancy is proportional to the concentration of the 
ligand  and  its affinity  for  the receptor;  the  magnitude  of the  biological response  to  the  chemical 
mixture can be predicted by summing the doses of the components after adjusting for the differences 
in potencies (US-EPA, 2007a; Boobis et al., 2008; EFSA, 2008a; WHO, 2009).  
2.4.2.  Dissimilar Mode of Action-Response Addition  
Dissimilar  Mode  of  Action-response  addition  (also  known  as  independent  action,  effect  addition, 
simple independent action and independent joint action, effect multiplication or Abbotts rule), assumes 
that a combination effect can be calculated from the responses of the individual components of a 
“mixture”  using  the  statistical  concept  of  independent  random  events  (Bliss,  1939;  EFSA,  2008, 
2013). In toxicological terms, response addition occurs when the chemicals act independently and by 
dissimilar or different MOA and possibly, but not necessarily, the nature and sites of toxic effects 
differ between the chemicals in a mixture, and one chemical does not influence the toxicity of another 
(US-EPA, 2000, 2007a; EFSA, 2008a).  
2.4.3.  Interactions 
Interactions occur “when the effect of a mixture differs from additivity based on the dose-response 
relationships  of  the  individual  components”.  Interactions  refer  to  joint  action  between  multiple 
chemicals that differ from dose addition or response addition and are categorised as less than additive 
(antagonism, inhibition, masking) or greater than additive (synergism, potentiation) (ATSDR, 2004a; 
US-EPA, 2007a; EFSA, 2008). 
-Antagonism, inhibition, masking 
Antagonism occurs when “the effect of the mixture is less than that estimated for additivity on the 
basis of the toxicities of the components.” Inhibition occurs “when a component that does not have a 
toxic effect on a certain organ system decreases the apparent effect of a second chemical on that organ 
system.” Masking occurs when “components produce opposite or functionally competing effects on 
the same organ system, and diminish the effects of each other, or one overrides the effect of the other” 
(ATSDR, 2004a; US-EPA, 2007a; EFSA,2008).  Combined exposure to multiple chemicals 
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- Synergism, Potentiation 
Synergism occurs when “ the effect of the mixture is greater than that estimated for additivity on the 
basis of the toxicities of the components”. Potentiation occurs when “a component that does not have a 
toxic effect on an organ system increases the effect of a second chemical on that organ system.” 
(ATSDR, 2004a; US-EPA, 2007a; EFSA, 2008a). 
Methodologies using dose addition, dissimilar mode action (response addition) and interaction for 
hazard assessment and risk characterisation of multiple chemicals are mostly applied to component-
based approaches (see Section 3.4 for a detailed account). 
3.  Overview of methodologies for the human risk assessment of combined exposure to 
multiple chemicals 
3.1.   Steps for risk assessment of combined exposure to multiple chemicals 
For multiple chemicals, the starting point of a risk assessment is to “frame the question” through 
problem formulation (Section 3.2). Risk assessors then go through the classical four steps of the risk 
assessment  paradigm  used  for  single  chemicals  (hazard  assessment  (hazard  identification,  hazard 
characterisation),  exposure  assessment  and  risk  characterisation.  For  both    exposure  assessment 
(Section 3.3), and hazard assessment (Section 3.4), a tiered approach is often applied and ranges from 
default/conservative assumptions in early tiers (tier 0 and 1) to more refined approaches based on 
increasingly data-informed and probabilistic approaches (tiers 2 and 3), depending on the purpose of 
the assessment  and  data availability. The results  of the exposure  and hazard assessment  are then 
combined for risk characterisation (Section 3.4).  
3.2.  Problem formulation 
In principle, problem formulation is the first step prior to performing a risk assessment of combined 
exposure to multiple chemicals and  some differences exist  between different agencies around the 
world.  
In  the  US,  the  Food  Quality  Protection  act  (FQPA)  requires  the  US-EPA  to  consider  combined 
exposure to multiple effects of exposure “to all pesticides and other chemicals that act by a common 
mechanism of toxicity when tolerances for pesticide use in crops are derived” (FQPA, 1996). From 
this legislative requirement, problem formulation has been defined by the US-EPA as “a systematic 
planning step to identify the major factors to be considered in a particular assessment in relation to 
preliminary hypotheses  with regards to  hazard assessment  (i.e. likelihood and severity of adverse 
effects which might occur or have occurred) and exposure assessment (i.e. likelihood and significance 
of exposure)”. From this definition, the US-EPA considers the outcome of the problem formulation 
process as a conceptual model that identifies the relevance of the exposure/co-exposure, the population 
exposed on the one hand and the chemical hazards and assessment endpoints on the other hand (hazard 
assessment)  to  finally  describe  their  relationships  (US-EPA,  2007a).  Typically,  if  the  problem 
formulation  demonstrates  that  the  likelihood  of  co-exposure  to  multiple  chemicals  is  low,  a  risk 
assessment may not be considered necessary. The ATSDR, the IPCS of the WHO and the three-non 
food Committees of the European Commission also consider likelihood of co-exposure as a key aspect 
of problem formulation so that multiple chemicals that would need a risk assessment or not can be 
prioritised  based  on  the  relevance  of  such-co-exposure  (US-EPA,  2003,  2007a;  ATSDR,  2004a; 
WHO, 2009).  
In  Europe  and  specifically  in  the  context  of  EFSA‟s  work,  problem  formulation  is  the  terms  of 
reference which requests a specific risk assessment for either single or multiple chemicals and is most 
often provided by risk managers from the European Commission or a Member State. The finalisation 
of  the  problem  formulation  step  often  requires  close  dialogue  between  risk  managers  and  risk Combined exposure to multiple chemicals 
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assessors to clarify the context of the requested risk assessment (e.g. pre-market or post-market risk 
assessment) so that the questions formulated have a sound scientific basis to optimise support to 
decision making and risk management. Two highly relevant examples within EFSA‟s context include 
the pre-marketing risk assessments for substances intentionally added to raw commodities such as 
pesticides in the context of Regulation (EC) No 396/2005 for which Cumulative Assessment Groups 
have to be defined to set Maximum Residue Levels (EC, 2005; EFSA, 2013) and risk assessment of 
undesirable substances in food such as contaminants (mineral oils, alkaloids…) (EFSA, 2012c, d, e).  
3.3.  Exposure Assessment 
Methodologies  for  combined  assessment  of  exposure  to  multiple  chemicals  have  been  reviewed 
extensively by the US-EPA (US-EPA, 200, 2003, 2007), the UK Committee on Toxicity of Chemicals 
in Food Consumer Products and the Environment (COT, 2002), the ATSDR (ATSDR, 2004), EFSA 
(EFSA, 2005, 2008a, 2013), the WHO (WHO, 2009; Meek et al., 2011) and the three Non-Food 
Committees of the European Commission (SCCS, SCENHIR, SCHER, 2012). Generally speaking, 
exposure scenarios can be set up for pre-market risk assessment and for post-market risk assessment 
and both address risk management questions with different input parameters in a tiered approach.  
In the context of the specific framework of authorisation of pesticides (pre-market risk assessment), 
the exposure assessment is in practice generally performed in the context of the MRL as a legal limit 
which is considered as the input safe limit value for the exposure assessment as a “conservative set 
tiered approach”. The MRL can be used as a worst-estimate of the chemical level in food in exposure 
models.  For  all  other  commodity/pesticide  combinations,  background  levels  estimated  from 
monitoring/field trial data are used and the combined exposure then consists of the summation of 
deterministic estimates of exposure for all chemicals (EFSA, 2012b).  
In contrast, for post market monitoring or exposure assessment of multiple undesirable substances  in 
food such as contaminants, most agencies around the world apply a tiered approach that will depend 
on the information available for dietary exposure assessment and range from tier 0 to tier 3 (from 
semi-quantitative  to  probabilistic  exposure  assessment).  Tier  0  is  often  used  to  generate  semi-
quantitative estimates of exposure (volume of production, usage of the chemicals, theoretical exposure 
estimates…). In addition, tier 0 can also be considered as a screening tool in order to rank/prioritise 
mixtures to be considered in a more refined assessment (WHO, 2009). 
Tier 1 is based on generic exposure scenarios using deterministic point estimates for both the food 
consumption and chemical levels in food. The food consumption estimates may correspond to food 
availability  or  food  consumption  statistics  (mean)  available  at  the  population  level  (EFSA  Food 
Consumption  Comprehensive  database;  EFSA,  2011a)  or  to  modelled  diets  (WHO  GEMS/Food 
cluster  diets).  Occurrence  for  the  chemicals  is  estimated  from  measurements  (monitoring 
data/experimental studies) or from reported usages levels.  
Tier  2  corresponds  to  a  deterministic/semi-probabilistic  estimation  of  exposure  refined  with 
incorporation  of  increasing  numbers  of  measured  values  at  the  level  of  occurrence  and  food 
consumption. For example, the estimation of exposure can take into account the full food consumption 
data  (mean,  high  percentiles)  at  the  individual  level  (EFSA  Food  Consumption  Comprehensive 
database) as  well  as  the  variability  of consumption patterns throughout the  population  of  interest 
(adults,  children,  pregnant  women,  vegetarians…)  (EFSA,  2011a).  Although  estimates  are  still 
considered conservative, they are more realistic than tier 1 estimates.   
Finally, Tier 3 would correspond to a full probabilistic exposure assessment combining distributions of 
chemical occurrence and individual consumption patterns. A spatial temporal dimension (for example, 
a  seasonal  variability  associated  with  some  consumption  behaviour,  or  differences  in  levels  of 
chemicals  in  food  present  in  the  market  according  to  the  EU  member  states  or  between 
imported/domestic  products)  may  be  taken  into  account  (EFSA,  2012b).  Additionally,  the Combined exposure to multiple chemicals 
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toxicokinetics  of  the  compounds  as  well  as  the  human  biomonitoring  data  and  biomonitoring 
equivalents may be used to estimate internal or absorbed doses from all exposure routes (SCCS, 
SCHER,  SCENIHR,  2012).  These  results  may  then  be  integrated  into  a  physiologically-based 
toxicokinetic  model  linking  external  dose  (exposure)  with  internal  dose  and  linked  to  a  full 
toxicodynamic model describing the toxicity of the mixture (Section 3.4). However, it should be noted 
that tier 3 approaches are not often used in practice because of the amount of data and the resources 
they require.  
Additionally, more sophisticated models and specific data may be required to apply tier 2 and 3 in 
order to combine the exposure to all chemicals. The exposure can be assessed independently for each 
chemical and then summed to estimate the combined exposure. A major drawback of this approach is 
that the correlations of occurrence and exposure between chemicals are not taken into account and 
such  correlations  may  be  of  importance,  especially  when  assessing  short-term  exposure  (EFSA, 
2012b). Ideally, in order to take such co-exposure correlation into account, occurrence data for the 
individual chemicals in individual samples are required. A typical example is European Regulation 
(EC) No 252/2012 which lays down methods of sampling and analysis in the framework of monitoring 
programs for the official control of levels for dioxins, dioxin-like PCBs and non-dioxin-like PCBs 
(EC, 2012a). The regulations require the systematic analysis in all food samples of 29 congeners of 
dioxins,  dioxin-like  PCBs  and  non-dioxin-like  PCBs  so  that  they  can  be  taken  into  account  in  a 
combined exposure assessment. Total Diet Studies (TDS) constitute another example that takes into 
account correlations of occurrence data for individual chemicals in individual samples. TDS consist in 
analysing a wide spectrum of chemicals in food “as consumed” and combined it with consumption 
data to characterise the long-term exposure profiles of the population to these chemicals.  
Finally, new modelling approaches have been explored in the context of the EU 7
th Framework project 
ACROPOLIS (for priority pesticides) selected on the basis of their known dose additivity to predict 
occurrence/exposure correlations. These modelling approaches may provide useful predictive tools in 
the future but would need further evaluation before they can be considered for routine use in exposure 
assessment. 
3.4.  Hazard Assessment and Risk Characterisation 
Traditionally,  hazard  assessment  (hazard  identification  and  hazard  characterisation)  for  combined 
exposure  to  multiple  chemicals  uses  either  the  whole  mixture  approach  or  component-based 
approaches depending on the toxicological knowledge of the mixture under assessment. In the context 
of multiple chemicals, the results of the hazard assessment is then combined with exposure data for 
risk  characterisation  (WHO,  2009;  Ragas  et  al.,  2010;  SCCS,  SCHER,  SCENIHR,  2012;  EFSA, 
2013). Both the whole mixture and the component-based approaches for hazard assessment use the 
concepts of Chemical class which has been defined as “a group of chemicals that are similar in 
chemical structure and biological activity, and which frequently occur together in the environment, 
usually because they are generated by the same process, such as manufacturing or combustion (e.g., 
polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins…) (US-EPA, 2000; ATSDR, 
2001, 2004a).“ Depending on the outcome of problem formulation, the concept of chemical class can 
include intentional mixtures such as substances subject to authorisation (pesticides, food additives and 
food contact materials, industrial chemicals under REACH…) (EC, 2006) or coincidental mixtures 
such  as  contaminants  as  undesirable  substances  (persistent  organic  pollutants,  marine  biotoxins, 
mycotoxins…). 
Generally speaking for hazard assessment,  a Reference  Point (RP) (also referred to as a point of 
departure (POD)) on the dose response relationship is identified from toxicity data using the same 
principle as that for single chemicals. RPs include the No-Observed Adverse Effect Level (NOAEL), 
Lowest-Observed-Adverse-Effect-Level (LOAEL) or the lower confidence limit of the Benchmark 
Dose (BMDL) (EFSA, 2009b).  Combined exposure to multiple chemicals 
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For thresholded (non-genotoxic) chemicals, the RP is divided by an uncertainty factor (often a default 
value of a 100 or if available a chemical specific adjustment factor) to allow for inter-species and 
inter-individual variability in toxicokinetics and toxicodynamics in order to establish a health-based 
guidance value (HBGV, also sometimes referred to as a Reference Value (RV) (Scientific Committee 
Opinion on default values in Risk assessment (EFSA, 2012f). In the Food safety area, HBGVs include 
the Acceptable Daily Intake (ADI) for food additives and pesticides, the Tolerable Daily Intake (TDI) 
for contaminants and chemicals in food contact materials and, for acute effects, the Acute Reference 
Dose (ARfD). In the risk characterisation, the estimated dietary exposure is compared with the HBGV.  
For compounds that are genotoxic and carcinogenic, the Margin of Exposure (MOE) approach has 
been developed by the WHO and EFSA for risk characterisation (WHO, 2005; EFSA, 2005a) in which 
the MOE is calculated by dividing the RP by the human exposure. The Scientific Committee (SC) of 
EFSA considers that MOE values of 10,000 or more, when based on a BMDL10 from an animal study 
and taking into account overall uncertainties in the interpretation are considered “of low concern from 
a public health point of view”. EFSA‟s SC notes that the magnitude of a MOE only indicates a level of 
concern  and  does  not  quantify  risk  (EFSA,  2005;  2009e;  2012g).  The  MOE  approach  has  been 
recently applied to the risk assessment of combined exposure to pyrrolizidine alkaloids and the safety 
assessment of genotoxic and carcinogenic impurities (EFSA, 2012d,e,g).  
As for exposure assessment, hazard assessment and risk characterisation of multiple chemicals (whole 
mixture approach/component-based approaches) follow a tiered approach and ranges from predictive 
methodologies and conservative assumptions in early tiers (tier 0 and 1) to more refined approaches 
based on increasingly data-informed and probabilistic approaches (tiers 2 and 3). 
 Tier 0 corresponds to an early-tier analysis where estimates of exposure and hazard are combined for 
risk characterisation and are simple semi quantitative estimates. In this context, default values can be 
used  for  the  hazard  part  when  no  toxicological  data  are  available  such  as  the  Threshold  of 
Toxicological concern (TTC) as proposed by the WHO for pharmaceuticals in water (Meek et al., 
2011) and the three Non-Food Committees for chemicals for which exposure is low (SCCS, SCHER, 
SCENIHR, 2012).  
In a Tier 1 assessment, the analysis can be refined by incorporating toxicity data on the potency of 
either  the  whole  mixture/individual  components  and  deterministic  estimates  of  exposure  may  be 
summed for the whole mixture/ components based on measured and/or modelled data. This type of 
analysis may be sufficient for risk characterisation and to determine whether further assessment is 
necessary. Tier 1 analysis often provides estimates that are based on broad, conservative scenarios 
with a limited numbers of parameters.  
In a Tier 2 assessment, chemicals maybe grouped into cumulative assessment groups (i.e. cumulative 
Assessment Groups/Assessment groups (see below Section 3.4.2 for a full discussion on the issue) 
using specific target organ information/MOA/MEA information or other types of information such as 
QSAR/molecular modelling information when available. For risk characterisation, when measures of 
potency are available for components of  an assessment  group (hazard), these can be applied and 
combined with deterministic estimates of exposure based on measured data and defined exposure 
scenarios.  
Finally, tier 3 assessment constitutes a rare data-rich situation for which it is possible to incorporate 
increasingly refined information on MOA and  distributions from physiologically-based models and/or 
biologically based dose–response models can be generated to describe variability in the population 
generated for the toxicity dimension (such as into . These distributions can then be combined with 
probabilistic  distributions from  the  exposure  assessment  (which  can include exposure  in  different 
populations and even aggregated exposures) for risk characterisation. These models can integrate both 
chemical-specific and more generic information on comparative physiology, biochemistry, and allow 
to  move  towards  a  more  quantitative  characterisation  of  interspecies  differences  and  human Combined exposure to multiple chemicals 
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variability.  In  such  probabilistic  assessments,  risk  estimates  are  also  expressed  as  probabilistic 
estimates (percentiles of the population exceeding an HBGV…) (US-EPA, 2007a). As discussed for 
tier  3  approaches  in  exposure  assessment,  tier  3  approaches  for  hazard  assessment  and  risk 
characterisation are not often used in practice because of the lack of data, the substantial resources 
they would require or the risk assessment does not require such a refined model.  
Methods  for  hazard  assessment  and  risk  characterisation  common  to  national  and  international 
agencies throughout the world are presented for both the whole mixture approach and component-
based approaches  
3.4.1.  Whole mixture approach 
The  Whole  Mixture  Approach  is  used  for  hazard  identification  and  characterisation  of  multiple 
chemicals when (1) toxicological data are available for the mixture itself  or (2) toxicity data are 
available  for  a  sufficiently  similar  mixture  composed  of  similar  chemical  components  in  similar 
proportions and can be used as a surrogate for the mixture of concern (US-EPA, 2000). 
Generally  speaking,  effect  data  can  be  derived  from  toxicological  evaluations  or,  if  available, 
epidemiological data (particularly for some environmental pollutants).The whole mixture approach 
has been used for mixtures that are poorly characterised (e.g. diesel exhaust fumes, tobacco smoke, 
gaseous  fractions,  whole  effluents  in  water…)  and  for  specially  designed  mixtures.  One  of  the 
disadvantages of the mixture approach is that toxicological testing of the whole mixture does not 
provide  specific  hazard  information  on  the  potential  interactions  or  toxicity  of  the  individual 
substances  present  in  the  mixture.  Recently,  the  three  non  food  Committees  of  the  European 
Commission concluded that, because the applicability of the whole-mixture approach is restricted to 
mixtures that do not significantly change in their composition, its use was not recommended as a 
general approach (US-EPA, 2010; SCCS, SCHER, SCENIHR, 2012; Wang et al., 2012). 
“Fraction” approaches and relative potency factors have been proposed to assess the toxicity of each 
fraction  (e.g.,  mixtures  of  petroleum  hydrocarbons  into  aliphatic  fractions  of certain  chain  length 
ranges and aromatic fractions, polyaromatic hydrocarbons) (US-EPA, 2010; Wang et al., 2012). The 
fraction approach can be considered as part of component-based approaches described below since 
toxicity data for surrogate chemicals are used for the whole mixture. 
3.4.2.  Component-based  approaches:  Cumulative  Assessment  Groups  and  Assessment 
Groups  
Component-based  approaches  constitute  methods  of  choice  to  group  “components  of  concern”  or 
“index chemicals” into cumulative assessment groups/assessment groups.  
 “Components of concern” have been defined as “chemicals in a mixture that are likely contributors to 
health hazard either because their individual exposure levels exceed health guidelines, or because joint 
toxic action with other components, including additivity or interactions, may pose a health hazard 
(US-EPA, 2000, ATSDR, 2001).  
An Index Chemical has been defined as “the chemical used as the point of reference for standardising 
the common toxicity of the chemical members of the CAG (US-EPA, 2007a). Historical examples of 
the index chemicals for the risk assessment of multiple food contaminants at EFSA include 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) for the assessment of dioxin-like compounds; benzo[a]pyrene for 
the  assessment  of  carcinogenic  polycyclic  aromatic  hydrocarbons  (PAHs),  lasiocarpine  and 
ergotamine for pyrrolizidine and ergot alkaloids respectively (EFSA, 2005b, 2008b, 2012d, e). 
A  Cumulative  Assessment  Group  (CAG)  has  been  defined  as  “a  group  of  chemicals  that  could 
plausibly act by a common MOA, not all of which will necessarily do so” (EFSA, 2008a, 2013). The Combined exposure to multiple chemicals 
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CAGs have been mostly set for pesticides by the US-EPA and the PPR Panel of EFSA (EFSA, 2013). 
As discussed before, the use of the term “cumulative” is a consequence of the use of cumulative risk 
assessment by the US-EPA and EFSA because of the legislation requirements for pesticides. In this 
context, the recent opinion of the PPR Panel presented a novel methodology for the setting of CAGs 
which was applied to pesticides affecting the nervous system and the thyroid system based on the 
same  toxicologically  relevant  effect  on  the  target  organ  induced  even  though  the  underlying 
biochemical events causing the effects were not demonstrated. (EFSA, 2013, see also Chapter 4.7.1)  
An Assessment Group (AG) considers the breadth of chemical diversity and has the advantage of 
being general and clear as long as the scientific rationale for grouping the chemicals is detailed in the 
specific hazard assessment. This term has been proposed by the IPCS/WHO (WHO, 2009) and will be 
referred to in this report. In this context, a number of options are available to the risk assessor to set 
AG based either on their structural properties (e.g. quantitative structure activity relationship (QSAR) 
and read-across methods), physico-chemical properties (partition coefficients for water and available 
organic phases…), their occurrence, co-occurrence and route of exposure (food, water, air…), their 
metabolic  and  elimination  patterns  (toxicokinetics) and their toxicity  (MOA).  Recent efforts have 
highlighted current and developing approaches for QSAR analysis of mixtures including techniques 
and software to combine chemicals into groups according to structural features (Muratov et al., 2012). 
However, a recent report of the Joint Research Centre of the European Commission concluded that 
even though there is a large  amount of data, software tools and promising models for predicting 
endpoints such as genotoxicity and carcinogenicity, further efforts will be needed to explore their 
applicability and practicality in routine application for regulatory setting (JRC, 2010; SCCS, SCHER, 
SCENIHR, 2012).  
Overall,  the  ultimate  goal  of  component-based  approaches  is  to  set  CAGs/AGs  for  multiple  to 
characterise the potential for combined toxicity from the combined exposure and the magnitude of 
such toxicity in individuals. Since not only chemicals with similar structural features occur together, 
setting CAGs/AGs requires the consideration of chemicals with a wide range of diverse structures and 
properties. As pointed out previously for pesticides, the PPR Panel of EFSA concludes that the lack of 
data  regarding  MOA  (basic  metabolism/toxicokinetics  and  key  events  leading  to  toxicity/MEA 
(molecular events) makes the setting of CAGs, a difficult task. Consequently, risk assessors may often 
have to rely on toxicological information from a higher level of biological organisation rather than 
MOA/MEA, such as target organ as the basis for the CAG/AG (EFSA, 2013).  
3.4.2.1.  Methods using Dose Addition  
In terms of hazard assessment and risk characterisation, dose addition sums the doses of the individual 
chemicals once relative toxic potencies between the individual chemicals have been quantified. The 
use of dose addition assumes that the individual chemicals in an CAG/AG either share a similar target 
organ/MOA/MEA and behave as concentrations or dilutions of one another differing only in their 
toxicological potencies (Bliss 1939; Finney 1971; US-EPA, 1986, 1999) or share similarly shaped 
dose-response curves for the endpoint being evaluated when using an index chemical to estimate risk 
(US-EPA, 2000, 2007a). 
Dose addition methods include the Hazard Index (HI) method with a number of variants (such as the 
target-organ toxicity dose and weight of evidence approach ), the Toxic Equivalency Factor approach, 
the RP index (RPI), also known as point of departure index (PODI) and Relative Potency Factor (RPF) 
approaches (US-EPA, 2000). For each method, the exposure levels are added after being multiplied by 
a scaling factor that accounts for differences in toxic potency. Extensive discussion of these mixture 
methods is given in the US-EPA‟s 2000 and 2007 Supplementary Mixtures Guidance (2000). If dose 
addition is applied using an index chemical to estimate risk, the mixture components are required to 
have similarly shaped dose-response curves for the endpoint being evaluated (US-EPA, 2000, 2007a). Combined exposure to multiple chemicals 
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Hazard Index method 
The Hazard Index (HI) uses the sum of hazard quotients for substances that affect the same target 
organ  or  organ  system.  The  Hazard  Quotient  (HQ)  is  the  ratio  of  the  potential  exposure  to  the 
substance to the level at which no adverse effect are expected such as an ADI, TDI or ARfD. If HI > 1, 
the total concentration (or dose) of mixture components exceeds the level considered to be acceptable. 
Appropriate interpretation of the HI requires detailed understanding of the individual chemical‟s dose-
response curves, the nature and commonality of the toxic effects and the quantitative relationship 
between the effect of concern and the critical effect (U.S. EPA, 2000, 2007a).  
The HI method has a number of advantages, the method has a long history of use, is well understood, 
it is easy to apply and provides a transparent index of acceptable risk based on established HBGVs.   A 
reciprocal  method (mathematical  inverse)  to  the  HI  is  the  Cumulative  Risk  (CI)  (Sarigiannis  and 
Hansen, 2012; SCCS, SCHER, SCENIHR, 2012). When extensive mechanistic information is not 
available, the HI is the preferred approach. When interaction data are available, the HI approach has 
been modified to take into account the nature of the interaction, the quality of available data, the 
plausibility of the interaction at actual exposure conditions and the relevance for human health (See 
Section 3.4.2.3 on interaction). 
Because it is based on HBGVs, which are not informative about the risks when exposure exceeds the 
HBGV,  the  HI  method  does  not  allow  prediction  of  the  overall  health  effect  of  the  combined 
substances but adds the strength of risk (roughly estimated), attributable to each component of the 
mixture. The HI is a risk characterisation approach based on comparing specific exposure to a HBGV 
for each component of the mixture. The HI approach also requires HBGVs to be available for all 
members  of  the  assessment  group,  which  is  often  the  case  for  pesticides,  but  less  likely  for 
contaminants. 
Target-organ Toxicity Dose (TTD) method 
The TTD method is a refinement of the HI approach which has been developed to take into account 
individual  components  of  a  mixture  either  as  an  index  chemical  or  individual  chemicals  from  a 
CAG/AG that may affect different target organs at doses higher than those responsible for the critical 
effect (used to derive the HBGV). Typical examples are waste-site-related mixtures. The ATSDR 
recommended that the TTD is based on the highest NOAEL that does not exceed the LOAEL for the 
particular endpoint. If such a NOAEL is not available, the TTD would be based on the lowest LOAEL 
for that endpoint. Additional considerations are that the NOAELs or LOAELs used as the basis for the 
TTD should be from a representative, quality study, for the same route and exposure period as the 
TTD. When data  for the exposure  duration  of  concern  are not available,  a TTD  derived for  one 
duration may sometimes be applicable for other duration(s) of the same route, if supported by the 
overall database. When suitable data are available, and when appropriate, TTDs can also be derived 
using  BMDL  values  (US-EPA,  2001,  2007a;  EFSA,  2009b).  For  either  the  index  chemical  or 
chemicals within a CGA/AG, a TTD for each endpoint of concern is calculated for endpoint specific 
effect for each chemical and is then combined with exposure data to derive and endpoint specific HI. 
When the endpoint-specific HI > 1, concern for the potential hazard of the mixture increases.  
Reference Point index or Point of departure Index  
The Reference Point Index (RPI, or Point of Departure Index) differs slightly from the HI since the 
sum of the exposures to each chemical component is expressed as a fraction of their respective RP for 
effects of toxicological relevance (i.e. NOAEL, LOAEL, BMDL) rather than as a fraction of the 
HBGV. The RPI is multiplied by an uncertainty factor (UF) which can be a default UF or a chemical 
specific  adjustment  factor  (CSAF)  depending  on  the  data  available.  Combined  risk  is  considered 
acceptable when the RPI is lower than a value of 1. The reciprocal of the RPI is the Combined Margin Combined exposure to multiple chemicals 
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of Exposure (MOET), where the individual margin of exposure (MOE) is the ratio of the RP to the 
level of exposure in humans (measured or estimated). MOET is calculated as the reciprocal of the sum 
of the reciprocals of the individual MOEs (EFSA, 2008a). According to the PPR Panel of EFSA, no 
established criteria to define the magnitude of an acceptable MOE for mixtures of chemicals with a 
threshold effect has been set yet. However, it is widely accepted that for MOEs above the uncertainty 
factor of 100, the combined risk is considered acceptable (EFSA, 2008a; Sarigiannis and Hansen, 
2012;  SCCS,  SCHER,  SCENIHR,  2012).  For  mixtures  of  chemicals  that  are  both  genotoxic  and 
carcinogenic, no established criteria have been set either for the magnitude of an acceptable MOE, 
however, the Scientific Committee of EFSA and the WHO have concluded that for a single substance 
a MOE of 10,000 was of low concern for public health (EFSA, 2005a). The CONTAM Panel has 
followed this approach for a number of groups of genotoxic carcinogens such as Aflatoxins, PAHs and 
PAs (EFSA, 2007b, 2008b, 2012d). 
Relative Potency Factors 
The Relative Potency Factor (RPF) (also known as Potency Equivalency Factor (PEF)) approach uses 
toxicity data for an index chemical in a group of multiple chemicals to normalise the potencies of all 
chemicals in the mixture assuming similarity of MOA between individual chemicals in the mixture. 
Usually the potencies are RPs derived from dose response curves and the combined toxicity of the 
mixture corresponds to the sum of the potency-normalised doses to yield a total equivalent exposure 
expressed as index chemical equivalents which is then compared to the HBGV. Combined risk is 
considered acceptable if such total equivalent exposure is lower than the HBGV of the index chemical. 
Alternatively,  the  MOE  of  the  total  equivalent  exposure  is  calculated  from  the  RP  of  the  index 
chemical  and  in  this  case,  if  needed,  additional  UFs  are  applied  to  the  individual  RPFs  before 
calculating the MOE. The RPF method is transparent, easy to use and has the advantage of providing a 
sound  basis for standardising  toxic  dose  metrics  and  separating  potency  correction  (hazard)  from 
exposure estimates. A key issue to bear in mind is the selection of the index chemical since great 
emphasis is placed on the quality of the toxicology database for which uncertainty should be the 
lowest possible (EFSA, 2008a). 
Toxic Equivalency Factors 
An important historical example of a specific type of RPF is the use of Toxic Equivalency Factors 
(TEFs) in risk assessment. TEFs were originally developed for the polychlorinated dibenzo-p-dioxins 
(PCDDs) and polychlorinated dibenzofurans (PCDFs), and subsequently the dioxin-like PCBs were 
included. For the individual congeners of these dioxins, toxicity data differ considerably depending on 
the number and position of the chlorine atom substituents (1-8) in the chemical structure. Based on 
available in vivo toxicity data, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was identified as the most 
toxic  congener  and  used  as  the  index  compound  with  a  TEF  value  of  1.  TEF  values  were  then 
calculated for each congener relative to TCDD, with values ranging from 0 to 1. TEFs were mostly 
based on in vivo toxicity data on animals, although in vitro data have also been considered in the 
absence of in vivo results. Toxic Equivalents (TEQs) are then calculated by multiplying the congener 
concentration in the mixture by its specific TEF "equivalent of TCDD" and the total TEQ of a mixture 
is then obtained as the sum of the individual TEQs. The resulting TEQs value express the toxicity of 
dioxins and dioxin-like PCBs in a complex sample in terms of the most toxic congener TCDD (Van 
der Berg et al., 2006). The WHO has derived TEFs for dioxins and dioxin like PCBs for both human 
(WHO, 1998), fish and wildlife in 1997 (Van den Berg et al., 1998) and updated the values in 2005 for 
human and mammalian species (Van den Berg et al., 2006). The compounds were included in the TEF 
approach using four inclusion criteria (Van den Berg et al., 1998) (1) structural similarity to PCDD; 
(2) capacity to bind to the aryl hydrocarbon receptor (AhR); (3) capacity to elicit AhR-mediated 
biochemical and toxic responses; and (4) persistence and accumulation in the food chain. Some toxic 
effects (especially of PCBs) may be independent of the AhR and these are not taken into account in 
the TEQs. Currently there are TEFs available for seven PCDDs, ten PCDFs and 12 dioxin-like PCBs Combined exposure to multiple chemicals 
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and these TEFs have been adopted formally for regulatory purposes in Canada, the European Union, 
Japan and the US.  
The  TEF/RPF  approaches  are  equivalent  to  the  MOET  approach  described  above  with  a  major 
difference in the stage at which the experimental data are compared to human exposure: in the case of 
MOET  the  comparison  is  performed  for  each  chemical  separately  (allowing  different  assessment 
factors  for  each  chemical).  In  the  case  of  the  RPF/TEF,  doses/effects  are  combined  using  one 
assessment factor for all chemicals in the group (Sarigiannis and Hansen, 2012).  
3.4.2.2.  Methods using response addition/dissimilar mode of action  
In terms of hazard assessment and risk characterisation, the probability of observing a toxic response 
for each chemical component in the mixture is first estimated and then the components are summed to 
estimate  total risk  from  exposure to the  mixture,  assuming  dissimilar/independent  MOA (i.e.,  the 
toxicity of one chemical in the body does not affect the toxicity of another chemical). This can be 
viewed as an organism receiving two (or more) independent insults to the body, so the risks are added 
under the statistical law of independent events (US-EPA, 2000, 2007a). In their recent opinions, the 
three  non  food  Committees  concluded  that  no  health  risk  would  be  anticipated  when  assuming 
response addition for threshold effects as long as the various exposure concentrations of the individual 
chemicals in the mixture would not exceed respective zero- effect levels. However, the Committees 
concluded that response addition would not apply to chemicals with non-threshold effects such as 
genotoxic carcinogens (SCCS, SCHER, SCENIHR, 2012). In contrast, response addition has been 
used for carcinogens in the late 1980‟s by the National Research Council (NRC) and it was concluded 
appropriate to sum the risks for the risk assessment of combined exposure to chemical carcinogens in 
the US (NRC, 1989).  
3.4.2.3.  Methods using assumption of interaction  
An understanding of the mechanistic basis for chemical interactions is critical to the hazard assessment 
and risk characterisation of combined exposure to multiple chemicals and three broad mechanisms 
have  been  identified:  direct  chemical-chemical  interactions,  toxicokinetic  interactions  and 
toxicodynamic interactions. 
- Chemical-chemical interactions describe mechanisms under which a chemical directly interacts with 
another, causing a chemical change in one or more compounds. The consequential effects of chemical-
chemical  interactions  may  lead  to  toxicity  which  is  either  1.  less-than-additive  such  as  antidotal 
treatments e.g. use of chelating agents to complex with metal ions (cyanide and cobalt compounds, 
ammonia  with  ingested  formaldehyde  forming  hexamethylenetetramine)  (ASTDR,  2004a),  or  2. 
greater-than-additive effects such as the gastric formation of carcinogenic nitrosamines after ingestion 
of  non-carcinogenic  nitrites  and  amines  (Klaassen,  1996)  or  the  increase  in  nephrotoxicity  of 
melamine  when  co-administered  with  cyanuric  acid  as  the  result  of  covalent  complex  formation 
(Jacobs et al., 2011). 
-  Toxicokinetic  interactions  between  chemicals  may  cause  deviations  from  additivity  affecting 
absorption,  distribution,  metabolism  and/or  excretion.  These  may  modify  elimination  patterns  or 
internal dose to target organ and may lead to effects (EFSA, 2012d). For toxicokinetic interactions, a 
key aspect to take into account is to determine whether deviation from additivity is synergistic or 
antagonistic and when the consequence of metabolism results in toxification or detoxification. Typical 
examples  of  toxicokinetic  interactions  include  competition/inhibition  of  transport  (absorption  and 
distribution) and inhibition/induction of metabolising enzymes (such as cytochrome P-450 (CYP). 
- Toxicodynamic interactions involve interactions between the biological responses from exposure 
(internal dose) to the individual substances in the mixture (EFSA, 2013). Combined exposure to multiple chemicals 
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A number of agencies have discussed that interactions of multiple chemical residues present at levels 
in food resulting in exposure below HBGVs are unlikely. For example, the Committee of Toxicity of 
the UK, PPR Panel of EFSA and the three Non-Food Committees of the European Commission have 
considered the evidence on the different forms of combined toxicity and their potential relevance to 
risk assessment for pesticide residues at the levels occurring in food and noted that although toxic 
interactions from pesticide residues in food cannot be ruled out, there is so far no empirical evidence 
for their occurrence at the expected levels of exposure from pesticide residues in food (COT, 2002; 
EFSA, 2008a, 2013; SCCS, SCHER, SCENIHR, 2012).  
 From a risk characterisation point of view, two major methods based on the HI method have been 
developed: the Interaction-based HI and the HI modified for binary interactions. 
Interaction-based Hazard Index 
An interaction-based HI (HI interaction) approach has been proposed as a modification of the HI approach 
assuming dose addition. The HI interaction is calculated using an uncertainty factor (either a default of 
10 or    a  data-derived  uncertainty  factor  quantifying  the  magnitude  of  interaction)  which  is  then 
combined with a numerical Weight of Evidence (WoE) score (negative for antagonistic interactions 
and positive for synergism)  according to tables  elaborated by the ATSDR and the US EPA. The 
numerical score takes into account key aspects of interactions: (1) nature of the interaction, (2) quality 
of the  available  data,  (3) biological/toxicological  plausibility  of the  interaction  at  actual  exposure 
conditions and (4) relevance for human health (US-EPA, 2000, 2007a; ATSDR, 2004a; Sarigiannis 
and Hansen, 2012). The method was originally proposed by Mumtaz and Durkin (1992) as the first 
systematic  attempt  to  address  the  need  to  take  into  account  interactions  between  components  of 
multiple chemicals and was then implemented and expanded by the National Research Council (NRC) 
of the United States (1989) to include extra uncertainty factors accounting for interactions among 
components of a mixture. Recently, the three Non-Food EU Committees discussed limitations of this 
approach which included (1) interaction-based HI provide only a numerical score of the potential risk 
related to a chemical mixture exposure; (2) both HI and interaction-based HI are strongly affected by a 
“subjective evaluation”; and (3) intrinsic uncertainties affecting HBGVs are combined and amplified 
in interaction-based HI derivation (SCCS, SCHER, SCENIHR, 2012). 
Hazard Index modified for binary interactions  
Another development of the HI approach is the HI modified by binary interactions (HI  BINinteraction).  
which evaluates hazard data for possible pairs of chemicals in order to determine qualitative binary 
WOE (BINWOE) taking into account effects of each chemical on their respective toxicity so that two 
BINWOEs are needed for each pair of chemical. As for the WoE, the BINWOE determination is a 
classification that indicates the expected direction of an interaction (greater than additive, less than 
additive, additive, or indeterminate), and scores the data qualitatively, using an alphanumeric scheme 
that takes into account mechanistic understanding, toxicological significance, and relevance of the 
exposure  duration,  sequence,  bioassay  (in  vitro  versus  in  vivo),  and  route  of  exposure.  The 
alphanumeric terms in the classification scheme can then be converted to a single numerical score, by 
multiplying the corresponding direction factor by the data quality weighting factor so that individual 
HQ can be modified taking into account binary interactions (ATSDR, 2004a; US-EPA, 2007a).  
3.4.2.4.  Physiologically-Based Models for multiple chemicals 
Physiologically-based  (PB)  models  are  useful  tools  for  high-tier  assessment  (tier  3)  of  combined 
exposure to multiple chemicals. These models are either called physiologically-based pharmacokinetic 
models  (PB-PK)  and  PB-PK-pharmacodynamic  models  (PB-PK-PD)  in  the  pharmacology 
/pharmaceutical field or toxicokinetic models (PB-TK) andPB-TK-toxicodynamic models (PB-TK-
TD)  in  the  toxicology  field.  Evaluation  and  use  of  such  PB-TK/TD  models  when  available  and 
appropriate have been proposed by the ATSDR, US-EPA, WHO and EFSA (ATSDR 2004a; US-EPA-Combined exposure to multiple chemicals 
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2007a; EFSA, 2008a; WHO, 2009; OECD, 2011; Meek et al., 2011). Generally speaking, PB models, 
separate the organism‟s body into one or multiple anatomical compartments of-biological relevance 
which are all connected to the blood circulatory system to form an integrated model and the transfer of 
chemicals between compartments is thus governed by blood flow rates and tissue solubilities (partition 
coefficients). Each compartment can have several sub-compartments consisting of a vascular section, 
an interstitial space, and a cellular space (Gerlowski and Jain 1983). The models are therefore built 
using: anatomical information (e.g., organ volumes and tissue sizes), physiological information (e.g., 
blood  flow  rates,  vascular  perfusion,  binding,  lipid  solubility,  ionization,  etc.),  thermodynamic 
information  (e.g.,  binding  isotherms),  and  transport  information  (e.g.,  permeability  of  the  tissue 
membrane, mechanisms of transport, sites of action and recently liver interplay at the transporter and 
enzyme level to optimise prediction of chemical absorption and sequential metabolism) (Himmelstein 
and Lutz,1979; Rowland, 1984; Fan et al., 2010). Krishnan et al. (1994) have listed over 45 parameters 
to build up such models and in view of the huge knowledge demands, these have been restricted to 
toxicological studies with specific test species and selected mixtures (Krishnan et al.,1994; Verhaar et 
al., 1997; Yang et al. 1995). However, because of their strong mechanistic foundation, PB-TK-TD 
models lend themselves to a detailed mathematical description of interactions between components of 
chemical mixtures and exposed species and have been therefore put forward for the development of in 
silico methodologies for the prediction of combined toxicity (Mayeno et al., 2005; Svendsen et al., 
2010).  
Over  the  last  decades,  application  of  PB-TK  and  PB-TK-TD  models  to  multiple  chemicals  has 
increased tremendously for binary mixtures and more complex mixtures such as gasoline (Kannan et 
al., 2002; Dennison et al., 2003; Bois et al., 2010; Fan et al., 2010). Examples include PB-TK models 
to calculate interaction-based HI computed for central nervous system effects using tissue doses t 
accounting  for  multiple  toxicokinetic  interactions  between  dichloromethane,  benzene,  toluene, 
ethylbenzene and m-xylene (Haddad et al., 1999, 2001; Kannan et al., 2002). More recently, PB-TK 
models for four solvents (styrene, benzene, ethylbenzene and toluene) were developed taking into 
account metabolic interactions at the level of their oxidation pathway mediated via CYP2E1 (Cheng 
and  Bois,  2011).  In  the  pesticide  field,  a  PB-TK  model  was  developed  to  model  the  potential 
interactions between chlorpyrifos (CPF) and nicotine at the TK level to predict CPF‟s metabolite 
concentrations (in blood and brain). In addition, a TD analysis was performed to to compare prediction 
of brain acethylcholinesterase (AChE) inhibition with experimental data in the presence of CPF and 
nicotine. Overall, the authors concluded that co-exposure to nicotine and CPF altered CPF metabolism 
in vivo, resulting in altered AChE inhibition (Lee et al., 2010). Other PB-PK-PD models have been 
developed for the CPF and diazinon (DZ) and the models included a number of important metabolic 
steps such as CYP450 mediated activation/detoxification, B-esterases, butyrylcholinesterase (B-E) and 
AChE or paraoxonase-1 (PON-1) oxon detoxification. Since both insecticides were shown to inhibit 
the CYP-mediated metabolism in vitro in a concentration-dependent manner, the PB-PK model was 
modified to reflect the TK of the CYP inhibition (i.e. competitive vs. non-competitive), while B-
esterase metabolism was described as dose-additive, and no PON-1 interactions were assumed. The 
PB-TK model was then compared with previously published rodent oral TK data and TD data (AChE 
inhibition) for co-exposure to CPF and DZ. No differences between predicted TK and published TK 
data were shown for either CPF or DZ or their respective metabolites, while TD AChE inhibition was 
consistent  with  dose-addition.  The  authors  concluded    from  the  modelling  exercise  that  at  low 
environmentally relevant binary doses of CPF and DZ, the TK and TD of the mixture were expected to 
be linear and dose-additive respectively (Timchalk et al., 2008). 
The US-EPA has also proposed to use PB-TK models to estimate daily internal dose for simultaneous 
exposures  to  13  drinking  water  disinfection  by-products  (DBPs)  via  three  exposure  routes  (oral, 
dermal, and inhalation routes) and account for activity patterns affecting human contact time with 
drinking  water  (e.g.,  tap  water  consumed,  time  spent  showering),  building  characteristics  (e.g., 
household  air  volumes),  and  physicochemical  properties  of  the  DBPs  (e.g.,  inhalation  rates,  skin 
permeability rates, blood: air partition coefficients). Potencies between the different congeners of the 
DBPs are taken into account using a cumulative RPF approach integrating, dose addition and response Combined exposure to multiple chemicals 
 
EFSA Journal 2013;11(7):3313  26 
addition  to  produce  multiple-route,  chemical  mixture  risk  estimates  using  total  absorbed  doses 
(Teuschler et al., 2004). Recently, a lipid-based bayesian PB-TK model has been developed for a 
mixture of six polychlorinated biphenyls (PCBs) in rats to incorporate an internal exposure-response 
model applied to in vivo data linking population variability in enzyme induction (cytochrome P-450: 
CYP1A and CYP1B) and metabolic rate. Such models can simulate concentrations of highly lipophilic 
compounds in tissue lipids, without the need for partition coefficients and in this context can model 
PCB concentrations in multiple tissues for all dose levels and dose profiles (Sasso et al., 2012). 
PB approaches provide high tier tools (tier 3) for risk assessment of combined exposure to multiple 
chemicals and can provide quantitative insights on interspecies differences and human variability, 
extrapolate  experimental  data  from  high-to-low-dose  situations  and  route-to-route  and  ultimately 
integrate population variability in TK and TD in the risk assessment process. So far, these models have 
not yet been used by regulatory authorities for this purpose because of a number of limitations such as 
the need for detailed knowledge on TK/TD data of multiple chemicals (metabolism/TK data, MOA, 
MEA..)  to  develop  the  models  which  are  not  often  available,  the  the  fact  that  they  are  resource 
intensive,  require  specialised  expertise  and  may  not  always  fit  the  purpose  of  a  specific  risk 
assessment. based on a case by case basis depending on the purpose of the risk assessment and data 
availability. However, it can be foreseen that PB models may be increasingly used on a case by case 
basis depending on the purpose of the risk assessment and when more more basic TK/TD data and 
generic predictive tools become available. (Conolly et al, 2005; US-EPA, 2007a, EFSA, 2008a; Dorne 
et al., 2012). 
3.5.  Uncertainty Analysis 
Uncertainty analysis, in the context of a risk assessment of combined exposure to multiple chemicals, 
is critical to give a transparent and balanced picture. This includes discussions on potential sources and 
types  of  uncertainties,  sensitivity  analysis,  variability,  data  gaps,  strengths/limitations  of  the 
assessment  and  future  research  needed  (EFSA,  2008a,  EFSA,  2007a).  A  number  of  guidance 
documents and discussions related to uncertainty analysis have already been published, mostly in the 
context of single chemicals, and provide thorough recommendations on qualitative and quantitative 
uncertainty analysis (EFSA 2007a, 2008a, 2012; WHO, 2008; US-EPA, 2007a; NRC 2009; SCCS, 
SCHER, SCENIHR, 2012). For example, in 2006, the Scientific Committee of EFSA developed a 
guidance related to “Uncertainties in dietary exposure assessment” which proposed a tabular approach 
and a tiered approach to analyse each individual source of uncertainty on different levels depending on 
data availability and the purpose of the risk assessment: conservative assumptions and default values 
(tier 0), qualitative refined point estimate including an indicative range for unquantifiable uncertainties 
deterministic (tier 1), deterministic approach including a range of point estimates based on different 
combinations of assumptions, plus unquantifiable uncertainties (tier 2), probabilistic approach that 
includes a probability distribution for quantified uncertainties (tier 3) (EFSA, 2006). In the context of 
tier 3, the PPR Panel of EFSA published a recent opinion with specific guidance for probabilistic 
exposure assessment of single and multiple pesticide residues (EFSA, 2012) (see Section 4.5). 
 Uncertainty analysis for the risk assessment of combined exposure to multiple chemicals will also be 
guided by the  tiered approach followed for exposure, hazard assessment and risk characterisation 
i.e. the description of uncertainties will also depend on the level of knowledge, assumptions and the 
tier  used  in  the  assessment.  An  exhaustive  list  of  uncertainties  for  exposure  assessment,  hazard 
assessment and risk characterisation applied to multiple chemicals in food is not currently available 
and is beyond the scope of this document.  
Examples of uncertainties in the exposure assessment include the availability of occurrence data and 
food consumption and consequently the impact on the exposure assessment for multiple chemicals 
(default values (tier 0-1), deterministic (tier 1-2), probabilistic values (tier 3). Combined exposure to multiple chemicals 
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Examples  of  key  uncertainties  for  hazard  assessment  for  multiple  chemicals  would  include  the 
adequacy of toxicological database and assumptions (dose addition, response addition, interactions). 
Within the context of the tiered approach, uncertainties under tier 0-1 would be related to the limited 
knowledge based on default value for whole mixture/ index chemical in the AG. Within tier 1-2 and 
tier  3,  uncertainties  would  relate  to  knowledge  of  surrogate  for  toxicity  (i.e.  target  organ…) 
(deterministic) (tier 1-2) and knowledge of MOA, MEA, AOP for each individual chemicals in the AG 
and availability of PB-TK-TD model, respectively. 
For the risk characterisation, uncertainties are by definition a composite of the uncertainties of the 
tiered exposure and hazard assessment and include: 
-  Tier  0.Conservative  assumptions/semi-quantitative  risk  estimates  for  hazard  and  exposure.  
Uncertainties can be described qualitatively. 
- Tier 1: Risk estimates derived as HI based on point estimates for exposure and hazard. Under tier 1, a 
possible scenario can include exposure estimates based on limited analytical data for occurrence and 
food consumption patterns and hazard assessment based on a POD for an index chemical assuming 
dose addition. In this case, uncertainty analysis can be semi-quantitative with an indicative range for 
unquantifiable uncertainties.  
- Tier 2: Risk estimates derived as HI based on knowledge of MOA for individual chemicals of an 
assessment group combined with analytical data.A typical scenario of a tier 2 analysis would be a 
deterministic  exposure assessment based on food consumption  and occurrence data for individual 
chemicals of an assessment group and hazard assessment based on BDML for individual chemicals 
based on common MOA in the assessment group. Risk estimates would then be derived using HI and 
assuming dose addition. In this case, a range of point estimates for uncertainties can be given. 
- Tier 3: Risk estimates based on PB-TK-TD model and probabilistic exposure assessment. Under tier 
3, the influence of each variable within the exposure of the hazard (PB-TK-TD)  part can be modelled 
(sensitivity  and  variability  analysis).  In  this  case,  uncertainties  can  be  assessed  in  a  quantitative 
manner and can be given as distributions.  
Overall, uncertainty analysis in the context of a risk assessment of combined exposure to multiple 
chemicals allows for: 1. Identification of the sources and magnitude of uncertainty in a tiered manner 
(qualitative,  semi-quantitative  or  probabilistic)  associated  with  exposure  assessment,  hazard 
assessment and risk characterisation; 2. The opportunity to consider and identify data gaps, strengths 
and limitations of the assessment (whether further refinements of the assessment are needed), and 
3. Identification of future research. 
4.  National and International Frameworks dealing with the human risk assessment of 
combined exposure to multiple chemicals 
This chapter presents national and international frameworks dealing with the human risk assessment of 
combined exposure to multiple chemicals developed by a number of agencies throughout the world in 
chronological  order  namely  the  US-EPA,  the  ATSDR,  the  IGHRC,  the  Norwegian  Scientific 
Committee for Food Safety, the three Non-Food Committees of the European Commission, and EFSA. 
Specific methodologies common to frameworks regarding problem formulation, hazard and exposure 
assessment, risk characterisation and uncertainty analysis will not be presented here since they have 
been previously discussed in Chapter 3.  Combined exposure to multiple chemicals 
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4.1.  US-Environmental Protection Agency  
The US-EPA has had a pioneering role in the development of methodologies for the risk assessment of 
combined exposure to multiple chemicals and has published a number of seminal documents as early 
as the late 1980s which include in chronological order:  
- guidelines for health risk assessment of chemical mixtures (US-EPA, 1986); 
- guidance for identifying pesticide chemicals and other substances that have a common mechanism of 
Toxicity (US-EPA, 1999); 
-  supplementary  guidance  for  conducting  health  risk  assessment  of  chemical  mixtures  (US-EPA, 
2000); 
- guidance on cumulative risk Assessment of pesticide chemicals that have a common mechanism of 
toxicity (US-EPA, 2002); 
- framework for cumulative risk assessment (US-EPA, 2003); 
- concepts, methods and data sources for cumulative health risk assessment of multiple chemicals, 
exposures and effects: A resource document (US-EPA, 2007a).  
As discussed in the terminology Chapter (2), the US-EPA uses the term cumulative risk assessment 
which is broader than “combined exposure to multiple chemicals” since it deals with combined risks 
from aggregate exposures (i.e. multiple routes of exposure) to multiple agents or stressors which may 
include chemicals, as well as biological or physical agents (U.S. EPA, 2003a).  
The US-EPA approach for human risk assessment of multiple chemicals was first developed in 1986 
and  updated  in  2000  and  2007  (US-EPA,  1986,  2000,  2007a).  The  2007  publication“concepts, 
methods and data sources for cumulative health risk assessment of multiple chemicals, exposures and 
effects:  a  resource  document  “  integrates  previous  publications  and  provides  a  presentation  of 
concepts, scientific approaches, methodologies and data sources to identify specific elements for risk 
assessment of combined exposure to multiple chemicals without being a regulatory document or a 
guidance. The resource document focuses on two particular aspects 1) initiating factors and problem 
formulation for combined exposure to multiple chemicals together with procedures for data collection 
and evaluation; and 2) technical approaches for exposure and hazard assessment for characterising 
human health risks with a subset of cumulative risk issues (i.e. multiple chemicals, exposures and 
effects), with examples related to contaminated sites, drinking water and ambient air. Specifically, 
initiating  factors,  exposure  assessment  methods,  whole  mixture  approaches  and  component-based 
approaches for hazard assessment are addressed in details together with risk characterisation with 
particular  emphasis  on  the  inclusion  of  uncertainty  and  variability.  Additionally,  a  number  of 
innovative methodologies are proposed, which include:  
-  development  of  a  description  of  initiating  factors  for  risk  assessment  of  combined  exposure  to 
multiple chemicals and procedures for population characterisation, data collection and organization 
based on such initiating factors;  
- implementation of chemical grouping into assessment groups as a potentially helpful way to scope 
analyses into manageable pieces to be assessed as multiple chemicals with co-occurring exposures  
- approaches and data sources for the evaluation of the timing of exposures, including discussions of 
toxicokinetics and toxicodynamics;  
- integration of internal dose measurements to account for multiple route exposures;  Combined exposure to multiple chemicals 
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- further development of the quantitative method for the interaction-based HI, first introduced in the 
2000  mixtures  guidance  document  (U.S.  EPA,  2000a),  RPF  methods  across  exposure  routes  and 
integration of output from multiple effects modelling such as categorical regression models.  
Broadly speaking, the US-EPA framework applies the risk assessment paradigm described in the US 
by the National Research Council (NRC) (NRC, 1983) in three steps: planning, scoping and problem 
formulation, risk analysis and risk characterisation.  
The planning, scoping and problem formulation phase aims to plans the goals, breadth, depth, and 
focus  of  the  assessment with a  focus  on specifying  the  chemicals  to  be evaluated, the  emissions 
sources and population to include (s). The end products of this phase are a conceptual model and an 
analysis  plan.  The  conceptual  model  establishes  the  stressors  to  be  evaluated,  the  health  or 
environmental effects to be evaluated, and the relationships among various stressor exposures and 
potential effects. The analysis plan lays out the data needed, the approach to be taken, and the types of 
results expected during the analysis phase (US-EPA, 2003). In contrast, problem formulation is dealt 
in Europe and at EFSA with the terms of reference where risk managers set the scope of the risk 
assessment (as discussed previously see Chapter 2). During the evaluation of chemicals of concern for 
a community, specific initiating factors are considered and any issues, sensitivities or vulnerabilities 
that  might  be  of  special  interest  to  stakeholders.  For  example,  the  population  profile  for  the 
community is also being examined to identify any increased incidence of morbidity/mortality that may 
be considered during the exposure assessment. (US-EPA, 2007a).  
The analysis phase aims to develop profiles of exposure and hazard, taking into account interactions 
(if any) amongst stressors, and to predict risks to the population (s) assessed. Difficult technical issues 
such as the toxicity of mixtures, the vulnerability of populations, or the interactions among stressors 
that may be chemical or nonchemical are addressed in this phase and, hopefully resolved. The end 
product of the analysis phase is an analysis of the risks associated with the multiple stressors to which 
the study population (s) are exposed (US-EPA, 2003, 2007a). Ensuring data quality and adequacy for 
both the exposure and hazard part of the assessment is an important step of the analysis phase which 
will guide the assessor to choose a qualitative assessment when data are inadequate, or either a whole 
mixture  or  a  component-based  approach  (US-EPA,  2000).  During  the  analysis  phase,  multiple 
exposure timeframes in which timing and intensity of exposures are examined relative to each other 
may be dealt with and chemicals may be grouped using their potential to co-occur (exposure routes, 
sources of emission) or their joint toxicity (target organ, MOA, potential TK or TD interactions) (US-
EPA,  2007a).  In  order  to  group  chemicals,  the  analysis  phase  includes:  1)  Classification  of  all 
chemicals of concern into initial groups by their potential to occur in the same or different media and 
at the same or different times; 2) further division of exposure/time groups into subgroups in which 
chemicals  are  thought  to  cause  toxicity  by  the  same  MOA  or  affect  the  same  target  organ; 
3) Assessment of the toxic potential of the chemicals and whole mixtures of concern. Refinements for 
both  whole  mixture  approaches  and  component-based  approaches  have  been  proposed  and  these 
refinements are illustrated in Figures 1 and 2 with a number of options depending on data availability 
and assumptions made. For the whole approach mixture, toxicological evaluations (i.e. RfDs, RfCs 
and slope factors discussed in Section 3.4.1) of the whole mixture of concern or a sufficiently similar 
mixture combined with exposure data enables the derivation of risk estimates or HQs. Refinement of 
the approach also allows for the use of epidemiological data when health endpoint, such as frequencies 
of illnesses in a population are available so that epidemiological risk measures can be derived. 
For  component-based  methods,  a  number  of  options  and  innovative  approaches  are  illustrated  in 
Figure 2 for hazard assessment, exposure assessment and the derivation of risk estimates for different 
scenarios: 
1. Multiple toxicological effect for each component of the group of multiple chemicals are available 
and  multi-variate  statistical  methods  have  been  proposed  (e.g.  categorical  regression).  Hazard Combined exposure to multiple chemicals 
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estimates can then be combined with component-based exposure assessment to generate risk estimates 
or HIs. 
2. Toxicological data for similar components (ideally based on MOA or target organ if MOA is not 
available) are available and combined with component-based exposure data, options are available for 
the derivation of risk estimates include  risk estimates based on BINWoE and interaction-based HI for 
interaction data, HI for dose addition assumptions, sum of route-specific index; chemical-based risk 
estimates, internal dose HI and multiple route internal doses using PB-PK models, index chemical-
based risk estimates or HQ using PB-PK models and integrated dose additivity models. 
3. Partial toxicological data for a combination of toxicologically similar and independent components 
(mixture of dose addition and response addition) are available and combined with component-based 
exposure data, a number of options are available for the derivation of risk estimates including internal 
dose HI, multiple route internal doses from PB-PK models or index chemical-based risk estimates/HQ 
from integrated dose additivity models. 
4. Toxicological data for independent components are available for the multiple chemicals and options 
include  assumption  of  response  addition  models/integrated  additivity  models  combined  with 
component-based exposure data to derive index chemical-based risk estimates HQ or risk estimates. 
 
 
Figure 1:   Refined whole mixture approach allowing for the use of epidemiological data (modified 
from US –EPA, 2007a) Combined exposure to multiple chemicals 
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Figure 2:   Refined  Component-based  approach  for  combined  exposure  to  multiple  chemicals 
allowing  for  the  use  of  categorical  regression,  PB-PK  models  and  integrated  additivity  methods 
(modified from US –EPA, 2007a) 
In the risk characterisation phase, the risk estimates derived in the analysis phase (HI, HQ, cumulative 
HI…) are put into perspective in terms of their significance, the reliability of the estimates, the overall 
confidence in the assessment and whether the assessment met the objectives and goals set  in the 
planning and problem formulation phase or not. A key part of risk characterisation is a discussion of 
the estimates of health risk in the context of uncertainties, assumptions made and variability and 
limitations in the data and methodology and estimates of health risks should be discussed within these 
perspectives (US-EPA, 2003). Recommendations associated with risk characterisation and uncertainty 
analysis in the context of multiple chemicals may be often more complex than those resulting from a 
single  chemical  assessment.  Key  factors  influencing  such  recommendations  include  the  lack  of 
understanding of combined toxicity due to missing data, subjective groupings of chemicals into AGs, 
confounding factors and exposure uncertainties associated with the use of epidemiological data…. In 
the case of the use of default values, the uncertainty analysis may be predominantly qualitative (e.g., 
default values for addressing interactions and multiple effects) (US-EPA, 2007a).  
4.1.1.  Application  of  the  US-EPA  framework  to  the  risk  assessment  of  combined  exposure  to 
multiple pesticides  
 Since 1996, the U.S-EPA has been required by the Food Quality Protection Act to assess combined 
risks from exposure to multiple pesticides  that act through a common MOA, for all pathways of 
dietary and non-dietary exposure (US-EPA, 1999). In 2002, the US-EPA published a guidance setting 
out the principles and framework for evaluating and estimating the potential human risks associated 
with multi-chemical and multi-pathway exposures to pesticides for this purpose  (US-EPA, 2002). Combined exposure to multiple chemicals 
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Typically,  individual  pesticides  in  the  common  MOA  group  have  been  assessed  for  aggregate 
exposures from food and drinking water, and non-occupational exposures prior to the risk assessment.  
Risk  assessments  have  been  conducted  for  five  groups  with  an  identified  common  MOA/MEA: 
organophosphates from an index chemical was adopted to standardise the toxic potencies and the RPF 
approach  was  used  to  determine  the  relative  toxic  contributions  and  for  risk  characterisation: 
Organophosphates  (OPs),  N-methyl  carbamates  (NMC),  triazines,  chloroacetanilides  and 
pyrethrins/pyrethroids and for which the MOA was characterised was adopted (US-EPA, 2001).  
For the OPs, methamidophos was selected as an index chemical based on its ability to bind to and 
phosphorylate AChE in the central and peripheral nervous systems. The exposure pathways of concern 
for OPs were identified as food, drinking water, and residential uses (US-EPA, 2006a). 
For NMCs, the US-EPA identified ten NMC pesticides for inclusion in an assessment group sharing 
the common MOA, excluding the thiocarbamate and dithiocarbamate because they did not share the 
same MOA. Three exposure pathways of concern were initially evaluated separately: food, drinking 
water  and,  residential/non-occupational  buildings  and  public  areas  and  duration,  frequency  and 
seasonality of exposure were incorporated for each of the exposure pathways. Exposure assessments 
for the residential uses and drinking water pathways were conducted on a geographical basis. oxamyl 
was selected as the index chemical, and the RPF method was applied using BMDL estimates for a 
10 % brain cholinesterase inhibition, to establish the toxic contribution of each NMC and determine 
the combined risk (US-EPA, 2007b).  
 For  triazines,  three  triazine  herbicides,  atrazine,  simazine  and  propazine,  and  their  metabolites, 
desethyl-s-atrazine, desisopropyl-s-atrazine and diaminochlorotriazine, were placed in an  AG. The 
grouping was based on a shared MEA through disruption of the hypothalamic-pituitary-gonadal axis, 
which  results  in  common  neuroendocrine  and  endocrine-related  developmental,  reproductive  and 
carcinogenic effects. Other triazines were excluded from the common mechanism group on the basis 
of dissimilar toxicity profiles. Propazine was not included in the assessment group on the basis that 
human  exposure  was  considered  unlikely  to  occur  from  the  registered  uses.  Potential  exposure 
pathways were identified as food, drinking water and residential activities on treated turf and addition, 
geographical  regions  of  likely  co-occurrence  were  identified.  Risk  assessments  for  the  multiple 
triazine exposures were conducted for scenarios with either single exposure pathway (drinking water) 
or  multiple  exposure  pathways  (drinking  water  and  residential  activities).  Quantitative  hazard 
estimates were derived using NOAEL values from a triazine toxicological database and toxicity for 
simazine,  propazine  and  the  metabolites  were  considered  to  be  equipotent  to  atrazine,  as  a 
conservative approach, based on endocrine-related data demonstrating either equal or less potency 
than that of atrazine (US-EPA, 2006b).  
Chloroacetanilide herbicides were assessed by considering acetochlor, alachlor and butachlor as a 
common mechanism group based on their ability to produce tumours of the nasal olfactory epithelium. 
Butachlor was excluded from the group on the basis that it had no product registration or established 
import tolerances. Based on the registered uses of acetochlor and alachlor, the US-EPA identified the 
exposure pathways to be evaluated as food and drinking water. NOAELs for nasal tumour formation 
were used to estimate the RPFs and express the contribution of acetochlor in alachlor-equivalent units 
(US-EPA, 2006c).  
 For  pyrethroids,  the  US-EPA  proposed  an  AG  for  pyrethrins  and  pyrethroids  based  on  shared 
structural characteristics, shared ability to interact with voltage-gated sodium channels and common 
neurotoxic  effects.  In  2011,  the  US-EPA  completed  a  screening-level  risk  assessment  for  the 
registered uses of pyrethrins and pyrethroids using the highest exposures/risk estimates across all 
exposure  pathways  of  food,  drinking  water  and  residential  use.  A  total  of  15  pyrethroids  and 
pyrethrins were included in the AG and a number of other pyrethroids were excluded based on low 
hazard or exposure potential. PB-PK models were available for a few compounds in the assessment Combined exposure to multiple chemicals 
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group  and  the  RPF  method  was  used  to  determine  combined  estimated  risk  of  the  group,  with 
deltamethrin as the index chemical (US-EPA, 2011). 
4.1.2.  US-EPA framework and Relative Potency Factors for PAHs 
Recently, the U.S. EPA applied the framework developed for whole mixtures using the RPF approach 
for  the  evaluation  of  carcinogenicity  of  PAH  mixtures  allowing  for  the  toxicity  of  unidentified 
components of PAH mixtures (US-EPA, 2000, 2007a, 2010). The rationale for such an evaluation lies 
in the fact that PAHs occur  as environmental contaminants as complex mixtures generated from the 
incomplete  combustion  or  pyrolysis  of  substances  containing  hydrocarbons.  Examples  of  such 
complex  mixtures  containing  PAHs  include  coal  tar,  manufactured  gas  plant  residues,  coke  oven 
emissions, diesel and gasoline exhaust, and coal plant emissions. The RPF approach involved two key 
assumptions related to a dose-additivity model (1) a similar MOA of PAH components in the mixture; 
and (2) interactions among PAH mixture components do not occur at low levels of environmental 
relevance.  Major  key  events  leading  to  the  observed  in  vivo  toxic  effects  of  PAHs  included: 
metabolism by CYP to reactive intermediates (e.g. dihydrodiol epoxides, quinones, radical cations), 
covalent DNA binding resulting in mutation with further tumour promotion and progression phases, 
parent compound binding to the Ah receptor and subsequent alterations of gene expression as well as 
cell proliferation response to the cytotoxicity of the reactive metabolites.  
A  database  was  developed  from  a  comprehensive  review  of  the  scientific  literature  on  the 
carcinogenicity and genotoxicity of PAHs (1950s- 2009), including 900 publications for 74 PAHs and 
600 papers that included carcinogenicity or cancer-related endpoint data on at least one PAH and 
benzo[a]pyrene  (BZPA)  tested  at  the  same  time.  References  were  classified  into  three  major 
categories: cancer bioassays, in vivo studies of cancer-related endpoints, and in vitro studies of cancer-
related endpoints and were further sorted by route (for bioassays) or by endpoint (for cancer-related 
endpoints). Each study was critically reviewed for use in the RPF determination using  a number of 
selection criteria including good quality of the study, reporting of quantitative results, concomitant 
testing of each PAH with BZPA, statistically significant increase in tumour incidence with BZPA 
administration compared with controls, observed carcinogenic response observed in either BZPA or 
other PAH-treated animals at the lowest dose level was not saturated (i.e. tumour incidence at the 
lowest dose was < 90 % with the exception of tumour multiplicity findings).  
Studies with positive findings and studies with non-positive findings (300 datasets) were used in a 
WoE approach for inclusion in the RPF approach, including dose-response data from at least one study 
for 51 of the 74 PAHs. After BMD modelling of carcinogenicity across multiple exposure routes using 
different models, BMDLs were derived to then calculate RPFs  as the ratio of the slope of the dose-
response curve for each PAH to the slope for BZPA with evidence for carcinogenic response for 24 of 
the  35  PAHs,  no  carcinogenic response for  3  PAHs  (anthracene,  phenanthrene,  and  pyrene),  and 
inadequacy of the data for 8 PAHs. Once a final RPF was derived for a given PAH, the resulting value 
was assigned a relative confidence rating of high, medium, or low confidence which characterised the 
nature and robustness of the database upon which the final RPF was based (available tumour bioassays 
and the availability of supporting data for cancer-related endpoints).  
Finally, characterisation of strengths, weaknesses, and uncertainties associated with the RPF approach 
to PAH cancer risk assessment were also discussed and key factors included the availability of in vivo 
data and multiple exposure routes (US-EPA, 2010). 
4.2.  Agency For Toxic Substances and Disease Registry  
In 2001, the ATSDR published a guidance for the “preparation of an interaction profile” and in 2004 a 
“Guidance Manual for the Assessment of Joint Toxic Action of Chemical Mixtures” both of which are 
consistent with the US-EPA approach, to assess combined exposure to multiple chemical at hazardous 
waste  sites  and  their  potential  impact  on  public  health  (ATSDR,  2004a;  US-EPA,  2000,  2007a). Combined exposure to multiple chemicals 
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Overall, the risk  assessment  is  performed  combining  exposure  data and toxicological  information 
(toxicological profiles, interaction profiles) on the mixture of concern (or a similar mixture) with 
similar strategies for non-cancer and cancer effects.  
The 2001 guidance was intended to evaluate data on the toxicology of 'whole' priority mixtures (when 
available) or binary mixtures, and to assess combined toxicity so that approaches for the exposure-
based assessment of the health hazard can be recommended. In this guidance, the ATSDR describes 
the  need  to  use  all  data  available  to  draw  conclusions  regarding  combined  toxicity  of  multiple 
chemicals with the exceptions of chemicals with data-rich interaction profiles and for which .a high 
quality  review  to  critically  assess  the  data  and  individual  studies  is  proposed(ATSDR,  2001). 
Following this guideline, the ATSDR has published case studies for a number of priority mixtures (see 
Section 4.2.3 for examples).  
The 2004 guidance is designed to be used in conjunction with the ATSDR Public Health Assessment 
Guidance Manual originally published in 1992 and revised in 2005 (ATSDR, 1992, 2005), which 
provides the primary  guidance for public health assessment, including aspects not covered in the 
mixtures  guidance  manual  and  includes  exposure  assessment  guidance,  recommended  sources  of 
health-based guidance values and toxicological information, and evaluation of health implications of 
other  medical  and  toxicological  factors,  sensitive  subpopulations,  uncertainties,  and  community-
specific health outcome data and concerns. The systematic method outlined in the 2004 guidance 
manual  reflects  an  exposure-based  screening  assessment  of  mixture  hazard  which  also  integrates, 
toxicological  profiles,  interaction  profiles  and  research  on  multiple  chemicals  (mixtures)  into  a 
practical screening approach for potential health hazards (ATSDR, 2001, 2004).  
Two  frameworks  are  proposed  namely  for  non-carcinogenic  and  carcinogenic  compounds  which 
follow a number of steps using a decision process based on exposure-based assessment of potential 
combined toxicity for human health assessment and make use of the interaction profile or policy 
guideline developed by ATSDR  (when available for the mixture(s) of concern). For both cancer and 
non-cancer effects specific approaches are focused on waste-site-specific exposure data for hazard 
assessment  including  whole  mixture  data,  assessment  of  single compounds,  PB-PK/PD, TEF,  HI, 
TTD, WoE, indicator chemical or other approaches (ATSDR, 2004).  
4.2.1.  Examples of risk assessments and interaction profiles assessed by ATSDR  
A  number  of  examples  of  interaction  profiles  have  been  published  on  the  ATSDR  website 
(http://www.atsdr.cdc.gov/interactionprofiles/index.asp). A few examples are illustrated here:  
Dioxin-like compounds 
 PCDDs, PCDFs, coplanar PCBs and other structurally related halogenated compounds believed to 
share a common MOA, ATSDR used TEQs based on TCDD data to estimate the toxicity of the whole 
mixture consistently with other agencies (WHO, US-EPA, EFSA..).  
Chloroform, 1,1-dichloroethylene, trichloroethylene and vinyl chloride  
ATSDR  performed  a  risk  assessment  for combined  exposure  to chloroform,  1,1-dichloroethylene, 
trichloroethylene and vinyl chloride, typically found in the water of hazardous waste sites, using a 
WoE approach by first evaluating potential binary pairs of chemicals in lieu of data on the whole 
mixture and then concluding for various endpoints for the overall mixture. The pairwise evaluation is 
an exposure-based assessment of potential health hazards for a binary mixture and is dependent upon 
the availability of relevant toxicological data. All four chemicals were shown to have effects on the 
liver, kidney and developing organism while the immune system was a common target of three of 
them  (chloroform,  trichloroethylene,  and  vinyl  chloride),  and the  nervous  system  of  two  of  them 
(chloroform and trichloroethylene). Carcinogenicity was also an end point of concern for three of the Combined exposure to multiple chemicals 
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chemicals (chloroform, trichloroethylene, and vinyl chloride).  From the WoE, it was concluded that 
most of the health effects associated with exposure to these chemicals were the result of metabolic 
activation by CYP2E1 and the formation of metabolites that react with target tissues to cause toxicity, 
with the exception of the neurotoxic effects of chloroform and trichloroethylene. ATSDR proposed to 
use HI (additivity) for the whole mixture with the stipulation that the index may overestimate toxicity 
at higher exposure levels due to competition for metabolism by CYP2E1. 
Other interaction profiles have been published on the ATSDR website and include: 
- Arsenic, cadmium, chromium, lead 
- Benzene, toluene, ethylbenzene, xylenes 
- Lead, manganese, zinc, copper 
- Persistent chemicals found in breast milk 
- Persistent chemicals found in fish 
- Arsenic, hydrazines, jet fuels, strontium-90, and trichloroethylene 
- Cyanide, fluoride, nitrate, and uranium 
- Atrazine, deethylatrazine, diazinon, nitrate, and simazine 
- Chlorpyrifos, lead, mercury, and methylmercury 
4.3.  Scientific Steering Committee of the Norwegian Scientific Committee for Food Safety  
The  Norwegian  Scientific  Committee  for  Food  Safety  (VKM)  adopted  an  opinion  in  2008  on 
“Combined  toxic  effects  of  multiple  chemical  exposures” 
  which  describes  relevant  theoretical 
principles and chemical examples in food safety for the risk assessment of combined exposure to 
multiple chemicals. The scientific opinion was requested to the VKM by the Norwegian Food Safety 
Authority, to assess whether combined effects have adequately been addressed in the risk assessment 
of the VKM. The document is based on three reports on combined actions of chemicals (COT, 2002; 
Danish Veterinary and Food Administration, 2002, 2003) together with a review of available scientific 
literature published between 2003 and the time of publication of the opinion (VKM, 2008).  
The approach used by the VKM is a proposed framework. Generally, combined effects have been 
taken into account when groups of structurally similar compounds have been assessed (e.g. dioxins 
and dl-PCBs, organotin compounds, parabens and some algal toxins). The first step of the framework, 
illustrated in Figure 3, is to identify whether the combined chemical exposures act by a genotoxic and 
carcinogenic mechanism and in this case an MOE approach is proposed. If the chemical exposures act 
via a threshold mechanism there are several levels of refinements: common target organ, common 
MOA, common physiological function affected and assumptions of common action (dose addition, 
response addition, synergism or potentiation). 
- If the exposure to all components in the mixture is below their individual NOAELs and they act by a 
similar MOA, additive effects are expected.  
-  If the exposure to component(s) in the mixture is above the NOAELs for the individual component, 
combined effects due to interaction may occur.  
- If dose addition can be assumed (simple similar action) for all components, a common expression of 
the  hazard  can  be  assigned  for  the  mixture  or  the  concurrent  exposures  so  that  when  ADIs  are 
available, the HI method may be used and when ADIs are not available, the Margin of Safety (MOS) 
or PODI method may be used.  
-  If there is a well-known and strong similarity in „MEA‟ for all components in  the  mixture,  the  use 
of an index compound and the TEF model may be considered.  Combined exposure to multiple chemicals 
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- If the components act by response addition (simple dissimilar action), no combined effect is expected 
if exposure to all components in the mixture are below their individual NOAELs  
- If there is evidence of departure from dose addition (synergism, potentiation), the framework allows 
to take it into consideration in the risk assessment. 
 
 
Figure 3:   Framework  for  combined  exposure  to  multiple  chemicals  -  Norwegian  Scientific 
Committee for Food Safety (modified from VKM, 2008) 
4.4.  Interdepartmental Group on Health Risks from Chemicals (IGHRC)  
The  UK‟s  Interdepartmental  Group  on  Health  Risks  from  Chemicals  (IGHRC)  has  published  a 
guidance  document  on  “Chemical  Mixtures:  A  framework  for  assessing  risks  to  human  health” 
(IGHRC,  2009)  which  described  risk  assessment  processes  for  mixtures  in  UK  agencies  and 
government departments, and provided a framework, in the form of a decision tree, to guide regulators 
when assessing risks from chemical mixtures; 
The document concludes on a number of situations that require the need for a risk assessment related 
to combined exposure to multiple chemicals: 
- Potential for significant human exposure to occur, and  
- Direct evidence for toxicity of the mixture; or Combined exposure to multiple chemicals 
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- Evidence for synergistic interaction between substances that are known to occur together; or 
- Individual components in the mixture, the margins between measured/predicted levels of exposure 
and thresholds of toxicological effect are narrow or there are concerns that exposures may exceed 
thresholds of effect exist; or 
- Likely presence of other similarly acting substances; or 
- Chemicals that share aspects of their absorption, distribution, metabolism and elimination are present 
together and there is reason to believe that this may affect the levels of a toxicant at its target site. 
The framework/decision tree for risk assessment of combined exposure to multiple chemicals uses a 
step wise approach in agreement with frameworks described from other agencies (US-EPA, ATSDR, 
WHO, VKM). The decision tree is a 11 step wise approach which is not an all inclusive step-by-step 
guide to risk assessment of combined exposure to multiple chemicals but highlights key issues that 
have  to  be  considered  depending  on  multiple  chemicals  that  are  being  assessed  (whole  mixture, 
components), assumptions (dose addition, response addition, interaction), data availability and the 
need for a tiered approach. The IGHRC recommends a tiered approach, that will typically entail the 
use of precautionary default assumptions to compile a preliminary (Tier 1) assessment of risk which 
may then be refined by replacing precautionary defaults with measured data or the use of a more 
resource intensive modelling approach, e.g. PBPK modelling, to predict systemic doses (tier 2 and 3) 
(IGHRC, 2009). 
4.5.  International Programme on Chemical Safety/World Health Organisation frameworks 
for the risk assessment of combined exposure to multiple chemicals  
Over the last two decades, the IPCS of the WHO has been involved in harmonisation of approaches in 
chemical  risk  assessment  through  increasing  understanding  and  developing  basic  principles  and 
guidance on specific issues such uncertainty analysis in exposure assessment or as chemical specific 
adjustment  factors  in  risk  assessment  (WHO,  2005,  2008).  Recently,  an  IPCS  working  group 
developed a framework for the risk assessment of combined exposure to multiple chemicals (WHO, 
2009; Meek et al., 2011; OECD, 2011).  
The  framework  is  illustrated  in  Figure  4  and  builds  on  the  US-EPA  experience  as  a  tiered  and 
integrated approach dealing with problem formulation, exposure assessment and hazard assessment 
which are then combined for risk characterisation.  
Problem formulation is described as a decision-based analysis taking into account relevant hazard and 
exposure information at an early stage to scope the need for a framework analysis, which may identify 
data gaps and recommend research to generate relevant data. Particular emphasis is given to early 
consideration of potential for exposure (prior to any consideration of hazard) and in the case of no or 
minimal exposure further assessment would not be needed as recommended  by the US-EPA, the 
ASDR and the three Non-Food Committees of the European Commission (Meek et al., 2011). 
The framework then follows a tiered approach for both the exposure and hazard dimensions (described 
in  Chapters  3.2  and  3.3  for  exposure  and  hazard  assessment  respectively)  and  tiers  range  from 
predictive methodologies and conservative assumptions in early tiers (tier 0 and 1) to more refined 
approaches based on increasingly data-informed and probabilistic approaches (tiers 2 and 3), but only 
if  necessary.  Dose  addition  is  used  as  the  default  assumption  for  estimating  risk  in  all  tiers  and 
chemicals can be grouped into “AGs”. Risk characterisation is then performed by dividing a RP by the 
estimated exposure to calculate MOEs. Under the WHO framework, at any tier, the outcome of MOE 
analysis may conclude that there is no cause for concern based on assessment at the initial tier using 
conservative defaults and no further resources are invested or indicate excessive risk, in which case, 
the assessment should be refined, incorporating more data and more accurate models (i.e., additional Combined exposure to multiple chemicals 
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refinement in a higher tier). The evaluation of the adequacy of the MOE is dependent on the actual 
purpose  and/or  (legal)  framework  for  which  the  assessment  is  performed.  Factors  such  as  inter-
individual variation (including susceptible groups), interspecies differences, quality and robustness of 
the database, nature of the hazard, temporal aspects should be taken into account (see IPCS, 2009b, for 
additional  guidance).  Approaches  to  consideration  of  the  adequacy  of  the  MOE  should  be 
conservative,  but  commensurate  with  the  degree  of  uncertainty  at  each  tier  (Meek  et  al.,  2011). 
Finally, the extent of assessment and nature of recommendations for generation of additional data are 
based on a WoE approach upon the extent of the knowledge base, the magnitude of public health 
concern (i.e. taking into account margins between exposure and effect) and the objective of the risk 
assessment  (e.g.  implications  of  potential  risk  management  decisions)  (WHO,  2009;  Meek  et  al., 
2011).  
 
Figure 4:   IPCS  WHO  Framework  for  the  risk  assessment  of  combined  exposure  to  chemical 
mixtures (modified from Meeke et al., 2011) 
4.6.  Framework from the Non-Food Committees of the European Commission 
4.6.1.   Scientific  Opinion  on  toxicity  and  Assessment  of  Chemical  Mixtures  and  proposed  
Framework  
On the 22
nd December 2009, the European Commission was invited by the Council of Europe “… to 
assess  how  and  whether  relevant  existing  Community  legislation  adequately  addresses risks  from 
exposure to multiple chemicals from different sources and pathways, and on this basis to consider 
appropriate modifications, guidelines and assessment methods, and report back to the Council by early 
2012  at  the  latest”.  Consequently,  the  European  Commission  Health  and  Consumers  Directorate 
General  (DG  SANCO)  requested  the  three  Non-Food  Scientific  Committees  of  the  European 
Commission: the SCHER, SCENIHR and SCCS to produce a joined scientific opinion to advise the 
European Commission regarding toxicity and assessment of chemical mixtures on specific issues. Combined exposure to multiple chemicals 
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The joint opinion “Toxicity and Assessment of Chemical Mixtures” of the SCHER, SCENIHR and 
SCCS addressed chemical mixtures in terms of human and environmental risk assessment and since 
the latter is beyond the scope of this document, only the human health aspects of the opinion will be 
discussed here.  
Problem formulation is discussed highlighting the fact that in the vast majority of risk assessments 
only single substances are considered and that no generally applicable guidelines for the assessment of 
combinations  of  chemicals  are  available.  Two  categories  of  research  publications  in  the  field  of 
mixture  were  identified:  investigations  of  combined  effects  based  on  a  few  pure  chemicals 
(component-based) and “real world” complex mixtures (whole mixture) e.g. diesel exhaust fumes, 
tobacco smoke. In view of recent publications, the Committee discussed that it had become necessary 
to evaluate whether new EU guidelines should be developed for the assessment of chemical mixtures 
and  the  regulatory  framework  be  strengthened.  Finally,  the  Committees  highlighted  that  such  an 
evaluation would need to particularly take into account potential mixture effects at realistic exposure 
levels in the environment or diet, and health risks associated with low dose exposures to multiple 
chemicals. Methodologies for human risk assessment of combined exposure to multiple chemicals 
(“chemical  mixtures”)  were  reviewed  for  exposure  assessment,  hazard  assessment  and  risk 
characterisation (Chapter 3))  as  well as uncertainties  associated  with the  risk  assessment  process. 
Based  on  the  analysis  of  available  information,  the  Committees  reached  a  number  of  general 
conclusions  and made a number of recommendations regarding the toxicity and risk assessment of 
chemical mixtures:. These conclusions and recommendations were formulated specifically to answer 
the 6 questions from the terms of reference provided by the European Commission. 
Question 1 – Is there scientific evidence that when organisms are exposed to a number of different 
chemical  substances,  these  substances  may  act jointly  in  way  (addition, antagonism,  potentiation, 
synergies, etc.) that affects the overall level of toxicity? 
-There is evidence that under certain conditions, chemicals will act jointly to influence the overall 
level of toxicity and for chemicals with common MOA, toxicity can be generally described using dose 
addition. It is also highlighted that Dose addition when applied to components with unknown MOA 
may result in over-prediction of toxicity whereas response addition may underestimate toxicity. and in 
the case of unknown MOA, dose addition is preferable to ensure an adequate level of protection.  
-For  chemicals  with  a  different  MOA  (response  addition)  no  robust  evidence  was  available  that 
exposure to such mixtures may be of health concern if the individual chemicals are present at or below 
their zero-effect levels. However, the Committees stressed that it is important to note that NOAELs 
from experimental studies do not always represent zero-effect levels and are often associated with 
effect levels in the range of 5 to 20 %. Hence, it cannot be assumed that in all cases, exposures equal 
to  these  levels  may  also  contribute  to  mixture  effects  for  dissimilarly  acting  chemicals.  In  the 
examples  in  which  independent  action  provided  a  more  accurate  prediction,  dose  (concentration) 
addition slightly overestimated the actual mixture toxicity, which suggests that dose addition for risk 
assessment  of  chemicals  of  unknown  toxic  mechanisms  is  sufficiently  protective.  Interactions 
(including antagonism, potentiation, and synergies) were concluded to usually occur at medium or 
high dose levels (relative to the lowest effect levels) and were either unlikely or of a toxicological 
insignificant nature at low exposure levels below RPs. According to Boobis et al. (2011), “low dose” 
is defined as at or near or below doses that do not cause statistically significant effects in experimental 
studies, such as NOAELs or benchmark dose levels.  
Question 2 – If different chemical substances to which man/environment are exposed can be expected 
to act jointly in a way which affects their impact/toxicity on/for man and the environment, do the 
current assessment methods take proper account of these joint actions? 
Currently risk assessment on the combined effects of chemicals in a mixture is not commonly carried 
out, nor required by most EU regulations. Direct toxicity testing is performed with mixtures, for some Combined exposure to multiple chemicals 
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specific purposes only (certain formulations or waste water effluents) and such testing is generally 
limited  to  acute  effects,  whereas  joint  actions  between  chemicals  on  a  chronic  basis  are  equally 
important  and  much  more  difficult  to  estimate.  Current  risk  assessment  methods  dealing  with 
combined exposure to multiple chemicals can take into account and predict reasonably well, AGs for 
chemicals acting via dose addition and response addition but are generally only applied under specific 
circumstances.  In  contrast,  interactions  are  generally  more  difficult  to  assess  and  require  expert 
judgement  on  a  case  by-case  basis.  Specific  conditions  under  which synergistic  actions  might  be 
expected, i.e. the most relevant interactions with regard to the toxicological risk i.e. toxicokinetic 
interactions (including metabolic interactions) and toxicodynamic interactions, have been outlined. 
Question 3 - Several approaches for the assessment of the mixture effects of chemicals already exist 
such as dose addition and independent action. What are the advantages and disadvantages of the 
different approaches and is there any particular model that could be considered as sufficiently robust 
to be used as a default option? 
Dose  addition  was  concluded  to  be  sufficiently  robust  and  conservative  as  a  default  option  (see 
question 1) In addition,  BMDLs are the preferred RPs for dose response since they reflect the whole 
dose response with an associated confidence interval as opposed to NOAELs/LOAELs which are 
based  on  single  experimental  datapoints  and  values  depend  on  the  dose-spacing  used  in  the 
experiment.  
Question 4 – Given that it is unrealistic to assess every possible combination of chemical substances, 
what is the most effective way to target resources on those combinations of chemicals that constitute 
the highest risk for man and the environment? 
Since possible combinations of chemicals to which humans may be exposed are almost infinite, the 
Committees proposed a number of criteria to focus and prioritise combination of chemicals/mixtures 
of potential concern:-Human exposure at significant levels of exposure i.e. such as chemicals close to 
HBGVs for thresholded toxicants.  
- Chemicals that are produced and/or marketed as multiple substances or commercial mixtures that 
contain several substances and/or active ingredients and/or substances of concern (i.e. as defined by 
EU legislation, e.g. REACH, Classification labelling and packaging, pesticides and biocidal products 
legislation etc.). 
- Evidence for potential serious adverse effects for one or more chemicals at the likely exposure levels. 
- Likelihood of frequent or large scale exposure of the human population or the environment to the 
mixture. 
-  Persistence  of  chemicals  in  the  body  and/or  in  the  environment  since  high 
persistence/bioaccumulation is an important property of a component of a mixture. 
 - Evidence for potential interaction at levels of human and environmental exposure. 
- Predictive information from QSAR and structural alerts that chemicals act similarly. 
- Mixtures for which one or more components are assumed to have no threshold of effect such as 
genotoxic carcinogens should be given particular attention; a MOE or a lifetime cancer risk approach 
could be applied. 
In the case of exposure to one or more components close to threshold levels or HBGV, the mixture 
should  be  given  priority  for  assessment.  In  order  to  deal  with  combined  exposure  to  multiple Combined exposure to multiple chemicals 
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chemicals that are of no-concern, a TTC-like approach can be applied and its applicability in this 
context as been described elsewhere (Price et al., 2009, Boobis et al., 2011; Meek et al., 2011). 
 Finally, the Committees supported the use of the tiered approach proposed by the IPCS/WHO (2009) 
and  EFSA  (2008a)  since  the  generation  of  an  appropriate  dataset  for  hazard  characterisation  and 
exposure estimates for multiple chemicals is a difficult and time and resource intensive task. It was 
proposed that the extent of the testing and the study designs required for the multiple chemicals is 
determined after the application of the tiered approach once data gaps have been identified. 
Question 5 – Where are the major knowledge gaps with regard to the assessment of the toxicity of 
chemical mixtures? 
With regard to the assessment of chemical mixtures, major knowledge gaps included: 
- Human exposure to certain chemical mixtures in relation to sources of the exposure (where), patterns 
of exposure (how often) and time dependency (how exposure may change over time) and quantitative 
estimates (to what extent). Hence, there is a  need to better understand human and environmental 
exposures both through the use of monitoring and modelling such as PB-TK  or PB-TK-TD modelling. 
- Good information on MOA, there is neither an agreed inventory of MOA, nor a defined set of criteria 
on  how  to  characterise  or  predict  a  MOA  for  data-poor  chemicals,  or  to  group  chemicals  into 
assessment groups.  
-Since interactions between multiple chemicals are difficult to predict, particularly for chronic effects 
research is needed to define criteria for the prediction of potentiation or synergy. 
Question 6 – Does current knowledge constitute a sufficiently solid foundation upon which to address 
the toxicity of chemical mixtures in a more systematic way in the context of EU legislation? 
The Committees concluded that knowledge is insufficient for a solid foundation upon which to address 
toxicity of chemical mixtures in a more systematic way in the context of EU legislation. However, 
when interactions of toxicological significance can be excluded, components of a mixture have been 
identified and MOA information is available, the applications of either a dose or response addition 
model is proposed. The application of the dose addition approach relies on a number of assumptions 
including MOA, shape/slope of dose response curves for each component of the group for multiple 
chemicals/mixture. These assumptions may be generated by grouping of chemicals into categories and 
assessment groups but no internationally agreed or harmonised criteria for such grouping exist, adding 
to the uncertainties associated with this approach. On the other hand, the application of response 
addition  (independent  action)  approach  may  underestimate  combined  toxicity  of  similarly  acting 
chemicals  and  when  no  MOA  information  is  available,  dose  addition  method  is  preferred.  For 
interactions, a case-by-case basis since their prediction requires expert judgement. 
Finally, the Committees discussed that in silico and in vitro methodologies may provide pathway-
based toxicity evaluations (e.g. oxidative stress - genotoxicity) and identify common effects in the 
future. However, the Committees remained critical about the applicability of such technologies, citing 
the recent report of the US National Academic‟s Standing Committee on Use of Emerging Science for 
Environmental Health Decision which concluded that that “many challenges remain to be addressed 
before the findings from high-throughput screens and in silico models may be considered sufficiently 
robust and informative” (Rusyn and Daston, 2010).  
Based upon the conclusions summarised above, the Committees recommended a mixture- dependent 
decision tree/framework for the risk assessment of mixtures illustrated in Figure 4 which is a decision 
tree as opposed to a tiered approach (EFSA, WHO). However the decision tree is in line with the 
previous frameworks developed at the US-EPA, ATSDR, EFSA and IPCS/WHO). The main focus of Combined exposure to multiple chemicals 
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the decision tree regards the prioritisation of chemical mixtures of potential health concern and has 
been proposed to a number of different types for chemical mixtures: 
-  Substances that  are  mixtures themselves  (multi-constituent substances,  materials  of  unknown  or 
variable composition, complex reaction products or biological materials, UVCB). 
- Products that contain more than one chemical e.g. cosmetics, plant protection products; 
- Chemicals jointly emitted from production sites, during transport processes and consumption or 
recycling processes; 
- Several chemicals that might occur together in environmental media (water, soil, air), food items, 
biota and humans as a result of emission from various sources and via multiple pathways. 
Figure 5 illustrates the decision tree for the human risk assessment of combined exposure to multiple 
chemicals proposed by the three Non-Food Committees of the European Commission The first step is 
problem  formulation to  consider  the  significance  of  human  exposure  to the whole  mixture  or  its 
components (as described in 3.1 and elsewhere ) and in the presence of negligible exposure, no further 
analysis would be required in agreement with the ATSDR,US-EPA and WHO (ATSDR, 2004a; US-
EPA, 2007a; WHO, 2009; Meek et al, 2011). In the case of significant human exposure, the first 
question to answer is the availability of components of the mixture. In the case of combined exposure 
to  multiple  chemicals  that  are  below  RP  and  HBGV  and  considered  of  no-concern,  a  TTC-like 
approach has been proposed. However, in the context of combined exposure to single components and 
components of the mixture with a common MOA with exposure estimates above the above TTC 
values, further analysis is needed to refine the risk assessment. A dose addition model is used when 
evidence is available that the components of the mixture exert their biological/ toxicological effects 
via an identical or similar MOA or MEA and unless evidence for a significant interaction is available. 
In the case of evidence for the mixture components acting via a dissimilar MOA, the independent 
action model would be applied. The dose addition approach is proposed as a default approach when 
neither MOA nor dose-response data are available in order that the assessment provides adequate 
conservatism for public health protection.  Combined exposure to multiple chemicals 
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Legend:  *”Significant”  exposure  is  determined  by  the  frequency,  the  duration,  and  the  magnitude  of  exposure  as  any 
exposure produced by emissions capable to modify the natural background conditions. 
Figure 5:   Decision tree for the human risk assessment of combined exposure to multiple chemicals 
from the joint opinion of the three Non-Food Committees of the European Commission (modified 
from SCCS, SCENHIR, SCHER, 2012.) “Toxicity and assessment of chemical mixtures”  
As a consequence of the scientific opinion, the European commission replied to the council on the 30
th 
May  2012  to  summarise  the  conclusions  of  the joint  opinion  and  discussed the  need  for  priority 
settings, knowledge gaps, conclusions and recommendations for further work in this area. The future 
work areas are integrated in Chapter 5 (recommendations for future activities). Combined exposure to multiple chemicals 
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4.7.  European Food Safety Authority (EFSA) 
4.7.1.   Frameworks for human risk assessment of combined exposure to multiple pesticides in 
food developed by the Scientific Panel on Plant Protection Products and their Residues 
(PPR) 
Methodologies  for  human  risk  assessment  of  multiple  pesticides:  cumulative  and  synergistic 
risks 
In  their  2008  opinion, the  PPR  Panel  evaluated  “the  suitability  of  existing  methodologies  and, if 
appropriate,  the  identification  of  new  approaches  to  assess  cumulative  and  synergistic  risks  from 
pesticides  to  human  health  with  a  view  to  set  MRLs”.  The  Panel  critically  evaluated  existing 
methodologies for the human risk assessment of combined exposure to multiple pesticides (cumulative 
and synergistic risks) and proposed a tiered approach to both exposure and hazard assessment. The 
relevance  of  combined  toxicity  to  the  risk  assessment  of  multiple  pesticides  residues  at  levels 
occurring in food was considered and limited to the dose-addition assumption. Additionally, the Panel 
proposed the grouping of compounds into CAGs based on a number of criteria such as chemical 
structure, mechanism of pesticidal action, or on further refined toxicological data such as common 
toxic effect or, ideally MOA. Such grouping of pesticides using chemical/toxicological properties 
allows refinement of the grouping in a step-wise approach depending on data availability. 
The strengths and weaknesses of specific methodologies for hazard assessment of multiple pesticides 
were reviewed and the HI, the RPI, the RPF method and PB-TK models were considered the most 
applicable with increasing levels of complexity and refinement. Methods for exposure assessment of 
pesticide residues belonging to a CAG were discussed in terms of relevant scenarios and data and were 
also proposed to be refined in a tiered approach with increasing levels of complexity, ranging from 
standard deterministic methods through to a probabilistic characterisation of exposures for individual 
members of the relevant population and methodologies.  
The  criteria  identified  for  the  selection  of  compounds  in  CAGs  include  both  toxicological  and 
exposure considerations. These include: (i) frequency of detection in monitoring programmes; (ii) high 
use  based  on  surveys  or  sales  statistics;  (iii)  evidence  from  biomonitoring  data  for  the  general 
population  or  for  sub-populations/geographical  areas  of  “high”  intake;  (iv)  compounds  with  high 
exposures relative to their reference values; (v) risk assessment for combined exposure of multiple 
pesticides  (“cumulative  risk  assessment”)  carried  out  elsewhere  showing  possible  unacceptable 
exposure; (vi) high number of compounds in a group; and (vii) assumptions on future trends in use of 
pesticides. Furthermore, specific assessment may be required on a case-by-case basis where there is 
biological plausibility for an interaction between specific pesticide combinations at low, non-effective 
doses (below their respective NOAEL). 
 Consistently with the US-EPA and the WHO, a tiered approach for combined exposure to multiple 
pesticides,  single  route  (cumulative  risk  assessment  of  pesticides)  was  proposed  as  illustrated  for 
hazard assessment in Figure 6. As described in Chapter 3, the tiered approach allows for any of the 
hazard assessment methods to be combined with any of the exposure assessment methods so that the 
most  efficient  use  of  the  available  resources  can  be  achieved.  The  possible  combination  of 
methodologies for hazard and exposure assessment will depend on data availability and if a lower tier 
assessment does not give adequate reassurance of safety the risk assessor may progress to a higher tier 
method for either or both hazard and exposure assessment (EFSA, 2008a).  
 Human risk Assessment of combined exposure to multiple triazole fungicides in food  
 Subsequent to the adoption of the 2008 opinion, the PPR Panel applied the tiered approach to the risk 
assessment of combined exposure to a selected group of triazole pesticides in food (oral route) for both 
acute and chronic effects (EFSA, 2008a, 2009a). A step wise approach to the refinement of grouping Combined exposure to multiple chemicals 
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the triazole fungicides into CAG using criteria set in the 2008 opinion was proposed using analysis of 
the  chemical  structure,  specific  common  toxicological  effects,  and  respective  biochemical 
mechanisms. In total, 26 triazole fungicide compounds that share the common toxic moiety (i.e. the 
single triazole ring) and a common mechanism of pesticidal action were identified, which satisfied the 
first criterion for initial grouping. The common mechanism of pesticidal activity of all triazoles was 
identified as inhibition of CYP51 in mammals leading to specific toxic effects, which satisfied the 
second  criteria  for  refinement  of  the  grouping.  The  next  step  involved  further  evaluation  of  the 
compounds to identify a possible common MOA/MEA leading to specific toxic effects in mammals.  
For risk assessment of acute exposure, a WoE approach supported the grouping of 7 triazoles based on 
developmental cranio-facial malformations through a common MOA/MEA. Notably, this teratogenic 
effect was not found to be the most sensitive end-point for these 7 triazoles. It was recognised in the 
opinion that, while risk assessment for single compounds is typically based on the most sensitive 
adverse effect, this will not necessarily hold true for risk assessment of multiple compounds which 
ideally should be based on an endpoint selected on the basis of a common MOA/MEA (EFSA, 2009a). 
For  risk  assessment  of  chronic  exposure,  4  hepatotoxic  triazoles,  for  which  extensive  residue 
monitoring data are available, were added to the 7 triazoles from the CAG group for acute exposure. 
Hence, A CAG of 11 triazoles based on hepatotoxicity as the common target organ was set. The ADIs 
of five compounds were set based on hepatotoxicity whereas for the other compounds in the CAG 
end-point specific NOAELs (other than NOAELs used as the basis of the ADI) were identified to 
derive end-point specific “ADI” were determined by applying the standard SF (100 or, in the case of 
LOAEL, 1000). 
Four  exposure  scenarios  were  combined  with  the  results  of  the  hazard  assessments  for  risk 
characterisation.  These were acute actual exposure, chronic actual exposure, acute exposure relevant 
for MRL-setting and chronic exposure relevant for MRL-setting assessed at the level of the Supervised 
Trials Median Residue (STMR) and exposure estimates were derived using either a deterministic or a 
probabilistic approach. Risk characterisation was then performed for each of the four scenarios by 
calculating HI, adjusted HI (with several tiers of refinement on the exposure side), and applying the 
RPF method to either NOAELs or BMDs as the RP. Overall, this risk assessment proved valuable for 
testing the methodology and identifying the next steps before its routine implementation into risk 
assessment of combined exposure to multiple pesticides (EFSA, 2009a). The PPR Panel concluded 
that  the  tiered  approach  proposed  in  their  2008  opinion  can  be  simplified  by  starting  the  hazard 
assessment with a CAG as refined as the data would allow and using the same CAG in all steps of the 
assessment (see Figure 5). For exposure assessment, it was proposed to restrict each exposure scenario 
to two  tiers:  deterministic  and  probabilistic.  Finally,  the  Panel concluded that  although  the tiered 
approach is an appropriate way to address risk assessment of combined exposure to multiple pesticide 
residues, a number of issues need to be addressed before the risk assessment methodology can be 
applied  routinely.  One  of  the  main  limitations  is  the  current  lack  of  EU-wide  consensus  on  the 
composition of relevant CAGs, the level of protection provided by the exposure assessment, and the 
methodology needs to be refined, including defining percentiles of the population to set levels of 
protection.  
Generally, speaking the final risk assessment of combined exposure to multiple pesticides can be 
performed using the tiered approach (Chapter 3) in a deterministic or a probabilistic manner and the 
scheme needs to be applied for each of the identified exposure scenarios: actual acute, actual chronic, 
MRL-setting  acute  and  MRL-setting  chronic.  For  example  a  tier  one  would  use  a  hazard  index 
approach based on either ADI or ARfD. However,  the PPR Panel noted that although combinations of 
different tiers are in principle possible (e.g. deterministic and probabilistic),  most often in practice a 
first tier hazard assessment will be combined with a first tier exposure assessment, and a refined 
hazard assessment will be combined with a refined exposure assessment (EFSA, 2008a). 
 Combined exposure to multiple chemicals 
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Figure 6:   Tiered  hazard  assessment for  multiple  pesticides: revised  proposal from  the  Scientific 
Panel on Plant Protection Products and their Residues of EFSA (EFSA, 2008a) 
Probabilistic exposure assessment 
In 2012, the PPR Panel published a “Guidance on the use of probabilistic methodology for modelling 
dietary exposure to pesticide residues” which includes probabilistic methods for quantifying some of 
the major sources of variability and uncertainty affecting food consumption, residues and acute and 
chronic  exposures  to  pesticides  (EFSA,  2012b).  Guidance  is  provided  on  problem  formulation, 
including  definition  of  appropriate  scenarios  for  acute  and  chronic  exposure  assessment  in  the 
differing contexts of approval of new substances, MRL setting, authorisation of products, evaluation 
of residues found above the MRL, and annual reviews of residue monitoring data.  
For basic probabilistic assessments, pessimistic and optimistic models are presented to model the 
effects of processing and for residues below the level of reporting. Pessimistic models treat major 
uncertainties  using  assumptions  that  are  expected to  lead to  over-estimation of  exposure  whereas 
optimistic  models  treat  major  uncertainties  using  assumptions  that  are  expected  to  lead  to  lower 
estimates of exposure. A general approach is recommended for evaluating uncertainties affecting the 
model outputs and an appendix describes uncertainties associated with the methodology recommended 
for acute and chronic exposure assessment. Additionally, key issues, approaches and software to be 
considered  for  probabilistic  exposure  assessments,  are  described  with  some  recommendations  on 
further work particularly to make the methods described in the guidance to end-users in more practical 
forms, including software and more specific user instructions (EFSA, 2012b). 
Probabilistic modelling of combined exposure to multiple pesticides is also discussed in the opinion 
with particular focus on the use of RPF to combine exposures to different substances, and a basic 
methodology for addressing gaps in data on the co-occurrence of residues of different substances.  For 
a given CAG, correlations between the concentrations of different members in the same food sample 
should be taken into account for acute exposure assessment and in order to do so occurrence data for 
different CAG members in the same samples are needed. Such correlations may be negative when 
using one member of the CAG, it is less likely that another member of the CAG will be used on the Combined exposure to multiple chemicals 
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same crop. These issues are not relevant for chronic exposure assessment since this depends on the 
mean residues of each substance in each commodity and not on the specific combinations of residues 
present in individual samples or units of commodity. For some residue datasets, the same substances 
are measured in each sample and data are available as a complete matrix and in this situation, RPFs 
can be applied to combine all the substances into a single measure of combined potency for each 
sample, and probabilistic modelling can be applied in the same way as for a single substance for risk 
characterisation. Difficulties arise when the substances analysed differ between samples so that the 
matrix of samples by substances is incomplete and contains a mixture of positives, non-detects and 
missing values (EFSA, 2012b).  
Identification of cumulative assessment groups of pesticides  
In  2013,  the  PPR  Panel  published  a  “scientific  opinion  on  the  identification  of  pesticides  to  be 
included in CAG on the basis of their toxicological profile” in order to refine EFSA‟s work in this 
field and facilitate the implementation of these CAG in routine MRL-setting (EFSA, 2013).  
The approach suggests grouping of pesticides in a CAG when they cause the same toxicological effect 
on the same target organ or organ system even if he underlying biochemical events causing the effects 
are not clearly elucidated. However, if mechanistic information (i.e. MOA/MEA) is available, it can 
be used for refinement of the CAGs. On basis of the proposed general methodology and an evaluation 
of data presented in Draft Assessment Reports (DARs) supporting the approval of pesticides in the 
EU, CAGs were derived for pesticides affecting adversely the nervous system and the thyroid system 
respectively and are also presented in this opinion. CAGs for substances having effects on motor 
division, sensory division and autonomic division after after acute exposure and for substances having 
effects effects on motor division, sensory division autonomic division and neuropathological changes 
after  chronic  exposure  have  been  established.  For  substances  with  thyroid  toxicity,  CAG  were 
allocated for effects on C-cells anf for effects on follicular cells respectively (EFSA, 2013).  
The allocation of pesticides to CAGs required both development of a general methodology as well as a 
thorough review of the DARs for effects on individual organs and organ systems and the identification 
of pesticides relevant for dietary exposure. To fulfill the latter need, two projects were outsourced by 
EFSA  to  collect  toxicological  data  on  pesticides.  For  the  first  outsourced  project,  all  pesticides 
authorised  prior  to  31
st  of  May  2009  were  evaluated  and  from  such  data  collection,  a  grouping 
approach was presented starting from identifying toxicological target organs and organ systems and 
then subsequently refining the grouping by identifying a specific phenomenological effect. If data 
allowed,  the  grouping  was  further  refined  by  identifying  a  common  MOA  or  MEA.  The  data 
collection and approach proposed by the contractor was scrutinised and partly consolidated by the PPR 
Working Group (Nielsen et al., 2012). A second project was outsourced to re-evaluate the data and, to 
specifically identify pesticides having effects on the nervous system, the liver and the reproductive and 
developmental system. In addition, pesticides approved from 31 May 2009 until 1 January 2012 were 
included in the scope of the second project (Wolterink et al., 2013). 
The methodology included four major steps:  
1) Identification of the specific effects by: i) exclusion of local effects; ii) exclusion of non-adverse 
effects; iii) exclusion of effects not relevant to humans; iv) evaluation of the unambiguous nature of 
the effect; v) identification of non-specific effects. 
2) Characterisation of the specific effects 
3) Collection of data collection  
4) Grouping of pesticides into CAGs Combined exposure to multiple chemicals 
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A number of uncertainties and limitations in grouping of the pesticides according to a common or 
shared toxic effect in the absence of experimental information about actual combination effects have 
also been acknowledged. Uncertainty associated with substances interacting with similar molecular 
targets may potentially underestimate risks since chemicals that may also contribute to a common 
response may be ignored (upstream or downstream action in an effector chain or through a different 
pathway).  Thus,  a  higher  level  of  protection  may  be  provided  by  considering  a  wider  range  of 
chemicals. However, until MOA becomes available. The PPR Panel approach is currently the best 
option with the best use of the current science and information. Recommendations were also discussed 
in relation to gradual implementation for the setting and use of CAGs, including CAGs for all other 
relevant  organs  and  organ  systems,  inclusion  of  potency-related  parameters.  Need  for  better 
information regarding MOA/MEA in relation to multiple toxic effects was also flagged by the Panel as 
well as the need to promote researches in the field of cumulative risk assessment, reduce the level of 
uncertainties and include new substances to identify data gaps that should be filled for non-approved 
pesticides detected as food residues in EU (EFSA, 2013). 
Multiple pesticides acting via dissimilar MOA 
Since  recent  publications  suggesting  that  compounds  acting  by  dissimilar  MoA  are  relevant  for 
assessment  of  combined  toxicity  (Kortenkamp,  2007;  Christiansen  et  al.,  2008;  Moretto,  2008; 
Jacobsen et al., 2010; Refstrup et al., 2010), the PPR Panel has received a mandate to elucidate the 
particular relevance of dissimilar MOA for combined exposure to multiple pesticides (cumulative risk 
assessment).  In  preparation  of  this  opinion,  EFSA  launched  a  call  for  tender  to:  1.  collect  and 
scrutinise the relevant literature available; 2.summarise and assess the state of the science in regard to 
risk assessment of combined exposure to multiple chemicals by dissimilar MOA; 3.propose scientific 
criteria for establishment of CAG for substances for which a dissimilar MOA leads to a common 
(similar) effect; 4. Assess currently available approaches for risk assessment of combined exposure to 
multiple chemicals in food acting by dissimilar MOA. The final report “Investigation of the state of 
the science on combined actions of chemicals in food through dissimilar modes of action and proposal 
for science-based approach for performing related cumulative risk assessment” has been published 
recently  on  the  EFSA  website  (Kortenkamp  et  al;  2012).  The  initial  step  of  the  project  was  a 
comprehensive literature search starting from a previous “State of the Art Report on Mixture Toxicity” 
published for the European Commission by Kortenkamp et al. (2009). The report also deals with the 
different definitions of dissimilar MOA under different regulatory frameworks such as in the EU, the 
USA or different national frameworks and the consideration of cumulative risks under different pieces 
of EU legislation. Analysis of the quantitative differences between predictions for risk assessment of 
combined  exposure  to  multiple  chemicals  by  comparing  concepts  and  respective 
approaches/methodologies and mathematical models by dissimilar and similar MOA has been carried 
out. Predictions based on either dissimilar or similar MOA differed in all cases by less than one order 
of magnitude, even for mixtures/multiple chemicals containing a high number of components. The 
analysis revealed further that application of the concept/approaches for similar MOA would, with 
reasonable  confidence,  lead  in  all  cases  to  more  conservative  assumptions  compared  with  the 
application of concept/approaches for dissimilar MOA.  
The report also addresses the possible use of the relevance of both adverse and non-adverse effects 
below the ADI for risk assessment of combined exposure to multiple chemicals and the possible use of 
the  TTC  concept.  A  comprehensive  overview  regarding  data  requirements  for  regulatory  risk 
assessment in the food and feed sector in the EU is also given concluding that in several sectors the 
data obtained might be insufficient to carry out risk assessment on a routine basis. On the basis of the 
analyses carried out, the contractors provided working assumptions for carrying out risk assessment 
for multiple chemicals acting via dissimilar MoA (disregarding synergism and antagonism, disregard 
any exposures from non-food sources and consideration of only simultaneous exposure). A number of 
criteria were set and an overall approach for risk assessment combining dissimilar and similar MOA 
was proposed.Finally, the authors proposed a tiered framework analysis with cumulative assessment 
groups derived from dose addition as well as dissimilarly acting chemicals. At lower tiers of the Combined exposure to multiple chemicals 
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framework  analysis,  all  chemicals  relevant  for  the  exposure  scenario  under  investigation  can  be 
assessed, irrespective of their presumed MOA. At higher tiers, when the risk estimates at lower tiers 
are deemed unacceptable, chemicals known not to contribute to a relevant common adverse outcome 
can be excluded from the analysis. By way of further refining the analysis, criteria for the grouping of 
chemicals into CAGs based on their capability to affect a common adverse endpoint, should be applied 
(Kortenkamp et al ., 2012).Using the Kortenkamp et al. (2012) report and in order to complement and 
safeguard the general methodology developed for setting CAGs, the PPR Panel is currently developing 
a  scientific  opinion  in  which  the  relevance  of  dissimilar  MOA  for  risk  assessment  of  combined 
exspoure  to  multiple  pesticides  (cumulative  risk  assessment)  is  explored.  The  opinion  is  due  for 
publication by the end of 2013.  
4.7.2.  Risk  assessment  for  combined  exposure  to  multiple  contaminants  by  the  Scientific 
Panel on Contaminants (CONTAM)  
The EFSA‟s Panel on Contaminants in the Food Chain (CONTAM Panel) has applied the whole 
mixture approach as well as component-based approaches mostly using dose addition as the main 
assumption for the combined effects of multiple contaminants. Consideration of the potencies of single 
components has also been performed depending on the level of information available.  
A whole mixture approach was applied to mineral oil saturated hydrocarbons (MOSH) detected in 
food since information on the occurrence of individual MOSH was not available, and toxicological 
data  were  available  only  for  a  few  MOSH  complex  mixtures  of  variable  and  poorly  known 
composition.  Although  a  common  critical  effect  was  identified  (formation  of  hepatic 
microgranulomas) to occur at different potencies for most of the MOSH mixture tested, the MOA 
could not be clearly established. The NOAEL for the most potent MOSH mixture was compared to 
dietary  exposure  in  the  general  population  in  a  MOE  approach  for  the  risk  assessment.This 
conservative approach was justified by the substantial level of uncertainty regarding the chemical 
composition  of  the  MOSH  mixture  tested  and  the  overall  range  of  MOSH  to  which  humans  are 
exposed  (EFSA,  2012d).  A  whole  mixture  approach  was  also  applied  for  the  flame  retardants 
hexabromocyclododecanes (HBCDDs), predominantly consisting of three stereoisomers (α-, β- and 
γ-HBCDD). A BMDL10 for neurodevelopmental toxicity was derived using toxicological data from a 
single administration of the technical mixture in mice which was then adjusted to body burden to take 
into  account  toxicokinetic  differences  between  mice  and  humans.    The  body  burden  was  then 
converted to an estimated chronic human dietary intake using half life and human gastrointestinal 
absorption and. MOEs were then derived using this estimate and  human exposure (EFSA, 2011b).  
The  TEF  approach  was  applied  to  non-ortho  polybrominated  biphenyls  (PBBs)  in  view  of  the 
evidence on common MOA for the non-ortho PBB congeners (i.e. dioxin-like MOA: cytotoxicity and 
cell proliferation mediated by aryl hydrocarbon receptor activation) (EFSA, 2010). In the absence of 
substance-specific data on the non-ortho PBB congeners, the TEFs established by Van der Berg et al. 
(2006) for the corresponding non-ortho PCBs were assumed. A TEF approach was also applied by the 
CONTAM Panel to the evaluation of several groups of marine biotoxins including the saxitoxin group, 
based on the rationale that the toxins have a common neurotoxic MOA mediated by the disruption of 
the  voltage-gated  sodium  channels,  using  the  available  acute  toxicity  data  of  the  different  toxins 
following i.p. injection to establish acute TEFs (EFSA, 2009c). Similarly, TEFs were established for 
the  pectenotoxins  group  on  the  ground  of  a  common  MOA  mediated  via  cytotoxicity  through 
perturbation of the actin cytoskeleton and the available acute toxicity data for the different toxins 
(EFSA, 2009d).  
For PAHs, the CONTAM Panel concluded that the TEF approach could not be applied because of the 
inadequacy of the toxicological database and evidence for different MOA between PAH congeners. 
Hence, the CONTAM Panel initially used an index chemical approach with BaP as a marker of both 
the carcinogenicity and occurrence of PAHs in a MOE approach. The approach was then refined to 
use the sum of 4 specific PAH as a marker of both the carcinogenicity and occurrence since BAP was Combined exposure to multiple chemicals 
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sometimes not present when other important PAHs were. Here again it has to be assumed that the most 
important members of the group are represented (EFSA, 2008b).  
For pyrrolizidine alkaloids (PAs), a dose addition approach was applied. For PAs, the MOA consisted 
of hepatocarcinogenesis mediated by metabolic bioactivation and DNA-adduct formation. Evidence 
that  PAs  with  the  common  key  chemical  feature  of  double  C-C  bond  in  position  1-2  of  the 
pyrrolizidine ring) undergo a similar bioactivation leading to a common active metabolite responsible 
of  the  adduct  formation  led  the  Panel  to  consider  the  1,2-unsaturated  PAs  group  using  the  dose 
addition approach. Since specific data on carcinogenicity data were available for two substances only 
(riddelliine and lasiocarpine) out of the group considered in the opinion, no TEF approach could be 
applied and a MOE calculation was carried out by dividing the BMDL10 for lasiocarpine (the most 
potent  PA  for  which  data  were  available),  by  the  combined  exposure  to  all  the  detected 
1,2-unsaturated PAs as a conservative approach (EFSA, 2012d). Similarly, dose addition was also 
used in its opinion on ergot alkaloids (EAs)  by deriving a group Acute Reference Dose (ARfD) and a 
group  TDI  considering  all  the  relevant  EAs  to  be  equally  potent  as  the  most  active  EA  tested 
(ergotamine) (EFSA, 2012e).  
4.8.  Summary  
 This  review  of  the  frameworks/tiered  approaches  available  for  the  risk  assessment  of  combined 
exposure  to  multiple  chemicals  has  included  the  approaches  developed  by  the  US-EPA  (whole 
mixtures and component-based approaches), the two frameworks for cancer and non-cancer effects 
developed by the ATSDR, the decision trees of the Scientific steering Committee of the Norwegian 
Scientific Committee for food Safety (VKM), The Interdepartmental group on Health Risks of the UK 
(IGHRC) and the three non food committees of the European Commission and finally the approaches 
used  at  EFSA  for  pesticides  and  whole  mixture/index  chemical/TEF  approaches  used  by  the 
CONTAM Panel. Two major differences can be highlighted from all these frameworks. First of all, the 
US-EPA, ATSDR, WHO and three Non-Food Committees highlight that co-exposure is a key aspect 
of the prioritisation of multiple chemicals of priority so that when co-exposure is unlikely a risk 
assessment would be unnecessary. In the context of EFSA, problem formulation is provided by risk 
managers and would set the risk assessment question. For example, by legislation pesticides would 
need to be grouped by CAG to set MRLs based on the DAR Assessment (hazard data).   
Another  key  aspect  is  the  use  of  dose  addition  which  is  considered  as  the  most  relevant  and 
conservative approach by the WHO, three Non-Food Committees and the CONTAM and PPR panels 
of EFSA to set CAG/AG based on an analysis of empirical results for effects of combined exposure 
including to chemicals that induce critical effects by different MOA (US-EPA, 2007a; EFSA, 2008a; 
SCCS, SCENHIR, SCHER, 2012). In a small number of cases, dose addition has been reported to 
underpredict  effects  as  a  result  of  synergistic  interactions  and  recent  analyses  suggest  that  the 
magnitude of the underprediction is less than an order of magnitude (Kortenkamp et al., 2009). In the 
case of evidence suggesting deviations from dose addition, all frameworks allow the refinement of the 
risk assessment to integrate such interaction data in the risk assessment process. 
5.  Recommendations  for  future  activities  at  EFSA  on  risk  assessment  of  combined 
exposure to multiple chemicals in the food and feed safety area  
Terminology, methodologies and international frameworks developed for the human risk assessment 
of combined exposure to multiple chemicals over the last decade have been reviewed in this report. 
Key steps involve problem formulation and tiered approaches for both hazard assessment (ranging 
from semi-quantitative estimates to full PB-TK-TD models) and exposure assessment (ranging from 
deterministic to probabilistic approaches) which are then combined for risk characterisation.  Combined exposure to multiple chemicals 
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It  is  proposed  that  terminology  and  general  considerations  for  future  activities  at  EFSA  are  first 
discussed  and  specific  recommendations  are  then  focused  on  problem  formulation,  exposure 
assessment, hazard assessment, risk characterisation and uncertainty analysis. 
5.1.  Terminology and general considerations  
The first key area that would need further work is harmonisation of terminology when dealing with 
combined  exposure  to  multiple  chemicals.  This  task  is  not  straightfoward  since,  in  some  cases, 
terminology is bound to the legislation such as the term “cumulative risk assessment” for pesticides, 
which in the harmonised terminology proposed by the IPCS/WHO would be equivalent to “combined 
exposure to multiple pesticides, oral route” when dealing with food only or “combined exposure to 
multiple pesticides , aggregate exposure” when dealing with all sources and routes of exposure. In this 
case,  an  option  is  to  simply  state  both  the  term  bound  to  the  legislation  and  the  harmonised 
terminology.  Another  difficulty  in  the  harmonisation  of  terminology  is  related  to  the  different 
meanings between different disciplines such as human and ecological risk assessment.  An example is 
the use of the term bioavailability in human risk assessment which corresponds to the fraction of a 
chemical absorbed by the gastrointestinal tract whereas in ecological risk assessment, the term deals 
with the fate of a compound in soil.  
Regarding major general considerations for the risk assessment of combined exposure to multiple 
chemicals in the remit of EFSA, a number of key areas for future activities have been identified: 
- Harmonised methodologies for  human risk assessment of  multiple chemicals in food.  Guidance 
documents have been developed for human risk assessment of multiple pesticides (EFSA, 2008a, 
2009a, 2012b, 2013) and a guidance applied to a broader range of substances (including authorised 
substances and contaminants, thresholded substances and genotoxic carcinogens) would be of great 
value to EFSA.   
-Harmonised  methodologies  for  ecological  risk  assessment  and  animal  health  risk  assessment. 
Ecological risk assessment and animal health risk assessment are even less well developed than human 
health risk assessment and these two areas would need further developments in the food and feed 
safety  area.  A  major  data  gap  and  research  need  in  this  area  applies  to  understanding  species 
differences in toxicokinetic and toxicodynamic processes (including MOA) for single chemicals and 
multiple chemicals of relevance to the food and feed safety area as highlighted by the three Non-Food 
Committeess of the European Commission for the ecological field and the PPR Panel of EFSA when 
dealing  with  multiple  chemical  exposure  in  bees  respectively  (EFSA,  2012a;  SCCS,  SCENHIR, 
SCHER, 2012).  
Both activities would contribute to developing a consistent approach to the assessment of priority 
mixtures across the different pieces of EU legislation.  
A possible activity in the longer term is the development of methodologies for risk assessment of 
exposure  to  multiple  chemicals  combined  with  other  stressors  (e.g.  biological  hazards,  physical 
agents…).  
5.2.  Problem Formulation  
 Problem formulation is a first step prior to initiating risk assessment for multiple chemicals with the 
aim to produce a conceptual model that identifies the relevance of the exposure/co-exposure to the 
multiple chemicals, the population exposed on the one hand and the chemical hazards and  health 
endpoints on the other hand (hazard assessment) to finally describes their relationships (See Section 
3.2  and  US-EPA,  2007a).  These  hazard-based  (health  endpoints)  and  exposure-based  (chemical 
concentrations and multiple sources or release of chemicals) factors have been defined as initating 
factors by the US-EPA (US-EPA, 2007a). In order to optimise the process of problem formulation to Combined exposure to multiple chemicals 
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identify  chemicals  of  priority  prior  to  embark  on  risk  assessments  of  multiple  chemicals, 
recommendations for future activities include: 
- Exposure-based problem formulation 
Identification of multiple chemicals in the food and feed safety area for which human exposure is 
significant  and  has  been  quantified  either  through  use  and  occurrence  in  food  commodities, 
biomonitoring programmes, and/or sources of exposure and sub-groups of the population exposed 
(adults, children, high consumers…). 
-  Hazard-based problem formulation 
Identification  of  multiple  chemicals  of  concern  in  the  food  and  feed  safety  area  using 
toxicological/epidemiological  criteria  i.e.  toxicokinetic  properties  of  concern  (persistence  and 
bioaccumulation, evidence for toxicokinetic interactions), toxicodynamics properties of concern (high 
toxicity,  severity  of  effects  (genotoxic  carcinogens,  developmental  toxicity,  evidence  for  
toxicodynamic interactions). 
- Integration of exposure and hazard-based problem formulation  
Such  integration  of  exposure-based  and  hazard-based  problem  formulation  will  provide  guidance 
when  dealing  with  combined  exposure  to  multiple  chemicals  in  humans  taking  into  account 
differences in legal frameworks between regulated products (intentional mixtures: pesticides, food and 
feed additives, food contact materials, chemicals under REACH…) and contaminants (coincidental 
mixtures: persistent organic pollutants, marine biotoxins, mycotoxins…). This recommendation is a 
key action point from the European Commission which has been discussed in its letter to the European 
Council and a multi-agency ad-hoc working group of Commission services has been recently created 
to deal with this issue across legislation frameworks (EC, 2012c). 
5.3.  Exposure Assessment 
Exposure assessment is performed by combining occurrence data with consumption data available in 
populations using tiered approaches (deterministic to probabilistic approaches) and based on these 
principles, recommendations for future activities regarding human exposure assessment to multiple 
chemicals include: 
1. Collection of occurrence data for multiple chemicals of priority in individual food samples  
The identification of multiple chemicals of priority in food and feed safety is a key area for future 
activities at EFSA. Hence, collection of occurrence data for multiple chemicals (parent compound, 
metabolite,  biomarkers  of  exposure…)  in  individual  food  samples  is  needed  via  monitoring 
programmes  and/or  TDS  once  they  have  been  identified  using  either  scientific  criteria  based  on 
exposure (significant co-exposure), hazard (toxicokinetics, toxicity of concern , acute or chronic), 
susceptible populations, typology of food consumptions patterns, or from a legislative requirement 
(e.g. setting of MRLs for multiple pesticide residues). As recommended by the PPR Panel in their 
recent guidance on probabilistic exposure assessment, such data collection will provide co-occurrence 
data for multiple pesticides in individual food samples and the correlations of such co-occurrence for 
acute  exposure,  chronic  exposure  when  dealing  with  mean  values  or  higher  percentiles 
(95
thpercentiles) in food samples (EFSA, 2012). 
Collaborations with other agencies to gather data on the extent of exposure to chemicals of priority via 
other routes (inhalation, cosmetics…) is also a key area that would need further developments. This 
has also been recommended by the three Non-Food Committees of the European Commission and 
discussed by the European Commission in their letter to the Council of Europe (EU. 2012). Combined exposure to multiple chemicals 
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2.  Develop  case  studies/training  sets  comparing  deterministic  versus  probabilistic  methods  for 
combined exposure assessment to multiple chemicals 
The characterisation of the dietary exposure profiles of the European population to identify chemicals 
of priority using occurrence data, TDS and existing/other databases and tools (EFSA‟s comprehensive 
consumption  database,  surveys  from  Member  States,  framework  programmes,  monitoring 
programmes) could represent an important input to investigate exposure modelling approaches. In 
order to do so, further case studies/training sets (such the triazole fungicide opinion from the PPR 
Panel  (EFSA,  2009))  to  compare  exposure  estimates  obtained  using  either  deterministic  or 
probabilistic  methods  need  to  be  developed  for  a  number  of  multiple  chemicals.  Methods  and 
guidelines can then be adapted to co-occurrence of chemicals and the need of the exposure assessment 
for the multiple chemicals (left-censored data, acute exposure to defined mixtures, chronic exposure to 
regulated  substances  versus  contaminants,  chronic  exposure  to  substances  that  are  genotoxic  and 
carcinogenic….). Research in statistical methods to investigate exposure combinations to multiple 
chemicals would need also further developments in order to integrate the probability of the population 
or sub-groups of the population to be exposed to the  multiple chemicals of priority. 
3. Develop further methodologies to perform aggregate exposure assessment for multiple chemicals of 
priority  
As discussed in recommendation 1, collaboration with other agencies to gather data on the extent of 
exposure to multiple chemicals of priority via other routes (inhalation, cosmetics, water…) is a key 
area  that  would  need  further  developments.  Using  such  occurrence  data,  further  methodological 
developments are needed to quantify the relative contribution of the food /feed route versus other 
routes  of  exposure  so  that  aggregated  exposure  assessment  can  also  be  performed  for  relevant 
chemicals of priority.  
5.4.  Hazard Assessment and Risk Characterisation 
Methodologies and international frameworks available for hazard assessment of multiple chemicals 
(Sections 3.3 and 4) include the whole mixture approach or component-based approaches, the choice 
of either of these methods is often driven by knowledge of the toxicity (toxicity data for the whole 
mixture only, toxicity data for components available and the purpose of the risk assessment so that the 
relevant tier (0, 1, 2 and 3) can be used. Component –based approaches are preferred to whole mixture 
approaches  and  ideally  multiple  chemicals  can  be  grouped  into  assessment  groups  based  on 
mechanistic understanding of toxicity (target organ, MOA, MEA, AOP, PB-TK, PB-TK-TD). In order 
to  further  support  harmonisation  and  development  of  methodologies  for  hazard  assessment  of 
combined exposure to multiple chemicals, four recommendations for future activities at EFSA are 
proposed: 
1.  Gain  better  information  regarding  MOA/MEA  of  multiple  substances  from  toxicokinetic    and 
toxicity  studies  as  well  as  using  predictive  and  alternative  methodologies  (including  QSAR  and 
OMICs) for regulated and active substances such as pesticides (EFSA, 2013) and contaminants (whole 
mixtures/ index chemicals) to improve the basis for setting CAGs/AGs. 
2. Scientific basis for whole mixture approach 
In some cases, data are only available on whole mixtures and even if a component-based approach is 
preferred to set assessment groups, further developments regarding the scientific basis of the whole 
mixture approach is needed with regard to: 
-  Methods  for  hazard  assessment  of  whole  mixtures  containing  a  large  fraction  of  unidentified 
chemicals;  Combined exposure to multiple chemicals 
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- Defining statistical, chemical or toxicological evidence that is needed to identify whether a whole 
mixture is sufficiently similar in nature to another mixture so that it be applied as a surrogate. 
3. Scientific basis for assessment groups  
 The scientific basis for the setting of (CAGs/AGs) for the hazard assessment of multiple chemicals 
needs to be further explored bearing in mind data availability and the purpose of the risk assessment. 
This  is  particularly  relevant  to,  substances  for  which  regulatory  authorities  can  request  more 
toxicological data from industry to fill toxicological data gaps such as pesticides. In deed, the recent 
PPR Panel opinion on CAGs for pesticides has defined CAGs for the nervous system and the thyroid. 
Specific recommendations for future work in this area include  the setting of CAGs for pesticides 
targeting  all other relevant  organs/organ  systems,  inclusion  of  potency-related  parameters  and  the 
inclusion of non-approved pesticides detected as food residues in EU to identify data gaps (EFSA, 
2013). 
In contrast, for contaminants, which are either naturally occurring or undesirable but unavoidable, 
requesting more data is not an option unless data are generated through research programmes. As 
discussed for the problem formulation section, priority setting for chemicals can be based on exposure 
criteria, hazard/toxicity criteria and population criteria. In theory, the rationale for setting AGs can be 
based on physical properties, chemical structure information, routes of exposure, population-exposed 
and toxicity criteria (toxicokinetic parameters (metabolic route, half life..), toxicity parameters (mostly 
target  organ,  rarely  MOA  and  MEA…).  By  definition,  toxicological  criteria  are  used  in  hazard 
assessment and further exploration of such criteria for setting CAGs is needed particularly with the 
well recognised fact that MOA and MEA data are mostly unknown for chemicals and alsoto include a 
flexible and  predictive  approaches  taking  into account the  level  of  knowledge  and  complexity  of 
toxicity and gaps in the toxicological database for multiple chemicals. 
A key aspect to explore setting of AGs is MOA for both TK and TD aspects (taking into account 
interspecies  differences  and  human  variability)  and  the  appropriateness  of  grouping  chemicals 
according to TK or TD would need further work. 
In this regard, the appropriateness of using generalised approaches for chemical mixtures to set AGs 
would need to be further explored using decision criteria/WoE approach for a number of situations. 
- Criteria to determine that several chemicals share a common MOA or have similarly shaped dose–
response curves. 
 In the case of co-exposure to multiple chemicals for which either: 1) the MOA of the chemicals is/are 
unknown, or (2) the chemicals have the same target organ but different MOA, or (3) the chemicals 
have different target organs and MOA.  
Toxicokinetic data  
TK data may be a useful means to set CAGs particularly when the metabolic route is known to be 
amongst key events (key metabolic route, bioactivation to a toxic metabolite, toxicokinetic interactions 
at  the  level  of  absorption,  distribution,  metabolism  (such  as  inhibition  of  cytochrome  P-450)  or 
excretion). Criteria to set CAGs using TK data would need to be defined using a WoE approach 
including consideration of interspecies differences and human variability (relevance of the metabolic 
route in test species to the human situation, availability of human data on metabolism (in vitro /in 
vivo).  Combined exposure to multiple chemicals 
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Toxicodynamic data 
As discussed above for TK data, criteria to set AGs using TD (toxicity data, epidemiological data)  
would  also  need  to  be  defined  using  a  WoE  approach  including  consideration  of  interspecies 
differences and human variability (relevance of the TD endpoint in test species to the human situation, 
availability of epidemiological data for contaminants).  
Additionally,  if  needed  for  the  hazard  assessment,  exposure-based  criteria  such  as  route-based 
assessment  groups  (e.g.  when  performing  a  risk  assessment  for  contaminants  in  water…)  and/or 
population-based  criteria  (e.g.  need  for  a  risk  assessment  for  a  specific  population  –exposed  to 
particular group of chemicals) can be combined with toxicological-based criteria again depending on 
the level of knowledge available and the purpose of the risk assessment. 
3.  Collection  of  toxicokinetic  and  toxicodynamic  data  for  multiple  chemicals  of  priority  using 
systematic review approaches 
For  risk  assessment  of  combined  exposure  to  multiple  chemicals,  the  dose  addition  is  the  most 
common  assumption  and  critical  assessment  of  whether  this  assumption  applies  or  whether  an 
interaction assumption (synergism /antagonism) is more appropriate is often on a case by case basis. In 
order  to  critically  assess  tdose  addition  is  most  commonly  applicable  to  predict  the  toxicity  of 
chemical mixtures and to move towards more harmonised methodologies and to further explore the 
setting of CAGs for MOA as presented in Section 2, comprehensive data collection on TK and TD 
data  for  multiple  chemicals  in  humans  and  major  test  species  used  in  human  risk  assessment  is 
essential. In 2010, EFSA explored the possible use of the systematic review (SR) approach as a WoE 
approach in food and feed safety (EFSA, 2010). In order to support such data collection on TK and TD 
data, the EMRISK unit launched a procurement to collect data from the scientific literature on in vitro 
and in vivo metabolic interactions and in vivo synergistic toxicological effects of chemical mixtures in 
humans and test species used in human health risk assessment. It was proposed that the data collection 
should be performed for at least 100 chemicals of relevance to EFSA (contaminants, pharmaceuticals, 
pesticides, feed and food additives and food contact materials).  
Additionally, during the SR it has been proposed to collect summary statistics for subgroups of the 
human population (adults, children, elderly, etc.) and test species (rat, mouse, rabbit, dog) and perform 
meta-analyses so that quantitative aspects of interspecies differences and human variability for TK and 
TD can be included. The inclusion of such summary statistics will allow for the quantification of the 
differences between single compounds and mixtures in subgroups of the human population and/or test 
species  and  their  associated  variability  for  parameters  gathered  from  in  vitro  and  in  vivo  studies 
investigating  toxicokinetic/metabolic  interactions  (inhibitors  or  inducers  of  CYP  metabolism, 
modulators of absorption…) and in vivo studies investigating synergistic effects (EFSA, 2012). Such a 
data collection exercise will provide high tier (tier 2-3) training sets to contribute to defining scientific 
criteria to set AGs based on quantitative TK and TD data, explore probabilistic approaches for hazard 
assessment and potentially develop predictive models to reduce animal use for  risk assessment of 
combined exposure to multiple chemicals.  
This activity also addresses two key aspects discussed by the European Commission in their letter to 
the European Council: 
- understanding species differences in toxicokinetic and toxicodynamic processes (including MOA) 
for single chemicals and multiple chemicals of relevance. 
- Develop a consistent approach to the assessment of priority mixtures across the different pieces of 
EU legislation. Combined exposure to multiple chemicals 
 
EFSA Journal 2013;11(7):3313  56 
5.5.  Risk characterisation and uncertainty analysis 
In relation to uncertainty analysis, it is recommended to extend the guidance document for uncertainty 
analysis in exposure assessment to include hazard assessment in relation to multiple chemicals. Such 
guidance  will  support  the  activities  proposed  for  problem  formulation,  exposure  and  hazard 
assessment. 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
  Human risk assessment of combined exposure to multiple chemicals (chemical mixtures) is a 
challenge to scientists, risk assessors and risk managers particularly because of the complexity of 
the terminology and problem formulation, the diversity of chemical entities, and the toxicological 
profiles and exposure patterns in test specie and humans. This scientific report aims to describe the 
terminology  and  methodologies,  review  frameworks  developed  by  national  and  international 
agencies and discuss future activities at EFSA in this field.  
  The use of a harmonised terminology is an important step when dealing with multiple chemical 
and this scientific report refers to “risk assessment of combined exposure to multiple chemicals” in 
line with the terminology proposed by the International Programme on Chemical Safety of the 
World Health Organisation (WHO). However, the use of this terminology is not prescriptive, since 
the term “cumulative risk assessment” is used in the pesticide field for the settings of Maximum 
Residue Levels (MRLs) under Regulation (EC) No 396/2005. 
  Problem formulation is the first step prior to performing a risk assessment of combined exposure 
to multiple chemicals and throughout the world different approaches exist. The US-EPA approach 
aims to identify the classes /groups of chemicals to be assessed, the relevance and significance of 
exposure to such chemicals, the population (s) exposed and the assumptions formulated based on 
the knowledge/uncertainty related to the chemicals under assessment. Relevance of co-exposure 
has been acknowledged by the US-EPA, ATSDR, the WHO and the three non food committees of 
the European commission as the critical issue to prioritise multiple chemicals for which a risk 
assessment may be necessary. In Europe, in the context of EFSA‟s remit, problem fomulation is 
often dealt with the terms of reference which defines the hazard to be assessed within a particular 
legal framemework and is often provided by risk managers either from the European Commission 
or a member State. An example of high relevance is the risk assessment of combined exposure to 
multiple pesticides in food in the context of Regulation (EC) No 396/2005 for which Cumulative 
Assessment Groups have to be defined based on hazard data to set MRLs. 
  Methods for risk assessment of multiple chemicals integrate single substance estimates (semi-
quantitative  or  quantitative)  for  both  the  hazard  and  the  exposure  dimension  to  generate  risk 
estimates for the combined exposure and follow a tiered approach of increasing complexity. The 
refinement of the tier depends on data availability and the purpose of the risk assessment and 
ranges from semi-quantitative tier 0 analysis to a fully probabilistic tier 3 analysis.  
  For  hazard  assessment,  either  a  whole  mixture  approach  or  a  component-based  approach  is 
applied. The whole mixture approach is used when either toxicological data are available for the 
mixture  itself  or for  a sufficiently  similar  mixture  that  can  be  used  as  surrogate  data for the 
mixture of concern. Component-based approaches are methods of choice when dose response data 
for individual components are available so that substances can be grouped into assessment groups 
ideally with mode/mechanism of action information using two basic assumptions of additivity or 
interaction (synergism and antagonism).  Combined exposure to multiple chemicals 
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  Additivity is the most common assumption and states that combined toxicity of multiple chemicals 
is  additive  either  through  dose  addition  with  a  similar  MOA  or  response  addition  with  a 
dissimilar/independent MOA. Methods using the dose addition include Hazard Index with variants 
such as the target-organ toxicity dose, the reference point index/point of departure index, the 
relative potency factor approaches and the toxicity equivalency factor approach.  
  For multiple chemicals with a dissimilar MOA, response addition is applied. The probability of 
observing a toxic response for each chemical component in the mixture is first estimated and 
components  are  then  summed  to  estimate  total  risk  from  combined  exposure  to  the  multiple 
chemicals, assuming independent MOA. Using the assumption of interactions (toxicokinetic and 
toxicodynamic), combined toxicity for the multiple chemicals is categorised as less than additive 
(antagonism, inhibition, masking) or greater than additive (synergism, potentiation) and involve 
mostly.  Methods  for  deriving  risk  estimates  for  interactions  include  interaction-based  Hazard 
Index and Hazard Index modified for binary interactions.  
  For high tier risk assessment (tier 3), full probabilistic models can be developed for exposure 
assessment and physiologically-based toxicokinetic (PB-TK) models and physiologically-based 
toxicokinetic-toxicodynamic models for hazard assessment. A typical example of the use of a PB-
TK includes the derivation of interaction-based hazard index using tissue doses accounting for 
multiple toxicokinetic interactions between the multiple chemicals. 
  Uncertainty  analysis  in  the  context  of  a  risk  assessment  of  combined  exposure  to  multiple 
chemicals allows for the identification of the sources and magnitude of uncertainty in a tiered 
manner  (qualitative,  semi-quantitative  or  probabilistic)  associated  with  exposure  assessment, 
hazard assessment and risk characterisation. In addition, it provides the opportunity to consider 
identify data gaps, strengths and limitations of the assessment (whether further refinements of the 
assessment are needed) and make recommendations on future research. 
  Most  national  and  international  frameworks  described  in  this  report  apply  step  wise  decision 
trees/tiered approaches for the risk assessment of combined exposure to multiple chemicals based 
on the original framework developed at the US-EPA. These include the US-EPA, the Agency for 
Toxic  Substances  and  Disease  Registry  (ATSDR),  the  Norwegian  Committee  for  food  safety 
(VKM), the UK‟s Interdepartmental Group on Health Risks from Chemicals, the three Non-Food 
Committees of the European Commission (Scientific Committee on Health and Environmental 
Risks  –  SCHER,  Scientific  Committee  on  Emerging  and  Newly  Identified  Health  Risks  – 
SCENIHR,  Scientific  Committee  on  Consumer  Safety  –  SCCS)  and  EFSA.  Key  differences 
between frameworks include the separation of two different frameworks for cancer and non-cancer 
effects (ASTDR) versus the use of single tiered approach (three Non-Food Committees, WHO) 
and the use of dose addition as the basis of the setting of assessment groups unless evidence 
demonstrates  otherwise    and  requires  refinement  of  the  assessment  (WHO,  three  Non-Food 
Committees, EFSA).The EFSA framework developed by the PPR Panel has been developed for 
risk  assessment  of  combined  exposure  to  multiple  pesticides  in  food  and  applied  to  triazole 
fungicides and more recently for the setting of two respective CAGs for pesticides with toxicity on 
the nervous system and the thyroid system. The methodology proposed follows an effect based 
approach and the pesticides are grouped based on the occurrence of the same toxicologically 
relevant effect on a relevant target organ induced even though the underlying biochemical events 
causing  the  effects  are  not  demonstrated.  For  neurotoxic  pesticides,  active  substances  were 
allocated to CAGs for acute effects on motor division, sensory division and autonomic division 
and  for  chronic  effects  on  motor  division,  sensory  division,  autonomic  division  and 
neuropathological effects were established. For active substances having adverse effects on the 
thyroid  gland  were  allocated  either  to  CAGs  for  effects  on  C-cells  or  on  follicular  cells 
respectively. Combined exposure to multiple chemicals 
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  The CONTAM Panel has also applied dose addition using both whole mixture and component-
based approaches for a number of contaminants. The whole mixture approach has been applied to 
mineral oil saturated hydrocarbons and hexabromocyclododecanes. Component-based approaches  
have been included a TEF approach for non-ortho polybrominated biphenyls (PBBs) and several 
groups of marine biotoxins using and modelling of BMDLs for an index chemical to derive group 
Acute  Reference  Dose/Tolerable  Daily  Intake  (e.g.ergot  alkaloids)  or  margin  of  exposures 
(MOEs) (e.g. polyaromatic hydrocarbons, pyrrolizidine alkaloids).  
RECOMMENDATIONS 
  Future  activities  at  EFSA  for  the  human  risk  assessment  of  combined  exposure  to  multiple 
chemicals  in  the  food  and  feed  safety  area  are  proposed  based  on  a  number  of  sources:  the 
conclusions and follow up action from the European Commission in their reply to the European 
Council, a review of the literature and consultation of experts from EFSAs Scientific Committee, 
Scientific Panels and Units. 
  Harmonised terminology and methodologies for human risk assessment of combined exposure to 
multiple  chemicals  in  food  and  feed  are  key  objectives  that  need  further  work  at  EFSA. 
Additionally,  development  in  harmonised  methodologies  for  ecological  risk  assessment  and 
animal health risk assessment is needed. Both these activities would contribute to developing a 
consistent  approach  to  the  assessment  of  priority  mixtures  across  the  different  areas  of  EU 
legislation.  
  A  potential  activity  in  the  longer  term  includes  the  development  of  methodologies  for  risk 
assessment  of  exposure  to  multiple  chemicals  combined  with  other  stressors  (e.g.  biological 
hazards, physical agents…).  
  Future activities for problem formulation include the identification of priority chemicals using 
exposure-based and hazard-based criteria and their integration to provide guidance, taking into 
account differences in legal frameworks between regulated products and contaminants.  
  For exposure assessment, recommendations include the collection of occurrence data for multiple 
priority chemicals in individual food samples, the development of case studies/training sets in 
order  to  compare  deterministic  versus  probabilistic  methods,  and  methodologies  to  perform 
aggregate exposure assessment for priority chemicals.  
  For hazard assessment, further developments regarding the scientific basis of the whole mixture 
approach and the setting of assessment groups for component-based approaches particularly using 
mode  of  action  information  is  needed.  A  key  recommendation  is  to  gain  better  information 
regarding MOA/MEA of multiple substances since such data are lacking for most regulated and 
active substances (pesticides) and contaminants. Such data can be generated from toxicokinetic 
and toxicity studies as well as using predictive and alternative methodologies (including QSAR 
and OMICs). to improve the basis for setting CAGs/AGs. Data collection of toxicokinetic and 
toxicodynamic  for  multiple  chemicals  of  priority  in  humans  and  major  test  species  has  been 
identified as a future activity and has recently started with a procurement on “Systematic review 
on metabolic interactions and synergistic effects of chemical mixtures for human risk assessment” 
for at least 100 chemicals of relevance to EFSA.  
  Finally, the development of guidance for uncertainty analysis regarding hazard assessment and 
risk characterisation for multiple chemicals is also recommended.  Combined exposure to multiple chemicals 
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ABBREVIATIONS 
ADI: Acceptable daily intake  
AG: Assessment Group 
ARfD: Acute Reference Dose  
AOP: Adverse Outcome Pathways 
ATSDR: Agency for Toxic Substances and Disease Registry, 
BINWoE: Binary Weight of evidence 
BMD:Benchmark Dose 
BMDL: Benchmark Dose Limit 
CAG:Cumulative Assessment Group 
CSAF: Chemical-Specific Adjustment Factor 
CONTAM: EFSA Scientific Panel on Contaminants in the Food Chain 
DCM: EFSA‟s unit on Dietary and Chemical Monitoring 
EC: Euroepan Commission 
EFSA: European Food Safety Authority  
EMRISK: EFSA‟s Unit on Emerging Risks 
FIP: EFSA‟s unit on Food Ingredients and Packaging 
HBGV: Health-based guidance value  
HI BINinteraction:HI modified by binary interactions  
HI: Hazard Index 
HQ: Hazard Quotient 
IPCS: International Programme on Chemical Safety  
JRC: Joint Research Center of the European Commission 
LOAEL: Lowest-Observed-Adverse-Effect-Level 
MEA: Mechanism of Action 
MOA: Mode of Action 
MOE: Margin of Exposure  
NOAEL: No-observed adverse Effect Level Combined exposure to multiple chemicals 
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NRC: National Research Council  
PB-PK: Physiologically-based pharmacokinetic models  
PB-PK-PD: Physiologically-based pharmacokinetic pharmacodynamic models 
PB-TK: Physiologically-based toxicokinetic models  
PB-TK-TD: Physiologically-based toxicokinetic toxicodynamic models 
POD: Point of departure  
PPR: EFSA Scientific Panel on Plant Protection Products and their Residues 
PRAS: EFSA‟s unit on Pesticides 
QSAR : Quantitative Structural Activity Relationship 
RfC: Reference Concentration 
RfD: Reference Dose 
RP: Reference Point  
RPF: Relative Potency Factor 
RVs: Reference Values  
SAS:EFSA‟s unit on Scientific Assessment Support 
SCCS: Scientific Committee on Consumer Safety  
SCENIHR: Scientific committee on Emerging and Newly Identified Health Risks 
SCER: EFSA‟s Scientific Committee and Emerging Risks Unit 
SCF: Scientific Committee on Food  
SCHER: Scientific Committee on Health and Environmental Risks  
TDI: Tolerable daily Intake  
TEF: Toxic equivalency Factors 
TEQ: Toxic equivalent quotient 
TTC: Threshold of Toxicological Concern 
TTD: Target-organ Toxicity Dose  
US-EPA: United States Environmental Protection Agency  
WHO: World Health Organisation  
WoE: Weight of evidence 